Through our partners including @sanofi, our vaccine technology continues to reach people around the globe and our strategy of partnerships and R&D innovation continues to drive near-term value. Read more: ir.novavax.com/press-releases/2026-10-29-Novavax-Earns-12…
Novavax
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria. More on Wikipedia
-
Novavax
@Novavax
-
Novavax
@Novavax
Join us Thursday, November 5, as we report our third quarter financial results for 2026 and share key operational highlights.
Get the details and register here: ir.novavax.com/press-releases/2026-10-29-Novavax-to-Repor…
#earnings #financialresults -
Novavax
@Novavax
This week, members of our leadership team will participate in a couple of investor conferences, discussing the progress we’re making on our corporate growth strategy and what’s ahead.
Learn more about our upcoming events: ir.novavax.com/events -
Novavax
@Novavax
#news: Novavax continues to deliver through our partnerships with @sanofi and Takeda, with Nuvaxovid™ approvals in the U.S., European Union and Japan for the 2026-2027 vaccination season.
Read more: ir.novavax.com/press-releases/2026-08-28-Novavaxs-Partner… -
Novavax
@Novavax
We’re sharing our second quarter 2026 financial results today, highlighting continued progress on our corporate growth strategy.
Join our live call at 8:30 a.m. ET: app.webinar.net/MB6vVgYErnW
Read the full press release: ir.novavax.com/press-releases/2026-08-06-Novavax-Reports-…
#earnings #financialresults -
Novavax
@Novavax
Join us Thursday, August 6, as we report our second quarter financial results for 2026 and share key operational highlights.
Get the details and register here: ir.novavax.com/press-releases/2026-07-30-Novavax-to-Repor…
#earnings #financialresults -
Novavax
@Novavax
This week, members of our leadership team will participate in a fireside chat at the @BofA_Business Securities Health Care Conference, where they’ll discuss our corporate growth strategy.
Register for the webcast: bofa.veracast.com/webcasts/bofa/healthcare2026/s23is5.cfm
#poweringwhatspossible -
Novavax
@Novavax
Today, we’re sharing our first quarter 2026 financial results including the continued progress on our corporate growth strategy. Join our live call at 8:30 a.m. ET: app.webinar.net/dMQ1j57YqOv
Read the full press release: ir.novavax.com/press-releases/2026-05-06-Novavax-Reports-…
#earnings #financialresults -
Novavax
@Novavax
Join us Wednesday, May 6 as we report our first quarter financial results for 2026 and share key operational highlights.
Get the details and register here: ir.novavax.com/press-releases/2026-04-29-Novavax-to-Repor…
#earnings #financialresults -
Novavax
@Novavax
Today, we’re sharing our Q4 and FY 2025 financial results and the continued progress on our corporate strategy. Join our live call starting at 8:30 a.m. E.T. here: app.webinar.net/RO3Y2A8EZqP
Full press release: ir.novavax.com/press-releases/2026-02-26-Novavax-Reports-… -
Novavax
@Novavax
Join us next Thursday, February 26 as we report our fourth quarter and full year 2025 financial results and share key operational highlights.
More information: ir.novavax.com/press-releases/2026-02-19-Novavax-to-Repor…
#earnings #financialresults -
Novavax
@Novavax
#news: Novavax has entered into a non-exclusive license agreement with @pfizer for use of Novavax’s Matrix-M® adjuvant for up to two disease areas.
This new partnership shows our corporate strategy in action, and adds to the successful collaboration we have with Sanofi, among other major companies. We’re excited to be executing on our strategy to drive incremental value from partnerships and R&D innovation, with the potential to create new or improve existing products using Novavax’s differentiated technology platform. Ultimately, these partnerships increase access for the people who could benefit from products built with our technology and importantly drive incremental value for investors and for global public health.
Visit ir.novavax.com to get details on the potential value we are building with this partnership, including $30 million upfront, up to $500 million in milestone payments and more.
We’re excited to work with you, Pfizer.
Read more: ir.novavax.com/press-releases/2026-01-20-Novavax-Announce… -
Novavax
@Novavax
We’re looking forward to attending this year’s @jpmorgan Healthcare Conference.
Learn more: ir.novavax.com/press-releases/2026-01-07-Novavax-to-Parti… -
Novavax
@Novavax
#news: Novavax completes U.S. marketing authorization transfer to @Sanofi for Nuvaxovid™, following the EU transfer in October in line with its collaboration and license agreement as well as its corporate strategy. ir.novavax.com/press-releases/2025-11-04-Novavax-Complete…
-
Novavax
@Novavax
#news: Novavax executes planned site consolidation, further reducing cost footprint in line with our corporate strategy. Learn more: ir.novavax.com/press-releases/2025-10-22-Novavax-Executes…
-
Novavax
@Novavax
This #healthliteracymonth, we’re sharing accessible information on vaccines to empower people to make informed health decisions. Building #healthliteracy is essential to address uncertainties, strengthen confidence and ultimately improve global health. Watch to learn more.
-
Novavax
@Novavax
#news: Novavax continues to deliver on @Sanofi partnership, completing Nuvaxovid® EU marketing authorization transfer. ir.novavax.com/press-releases/2025-10-07-Novavax-Continue…
-
Novavax
@Novavax
Novavax has further deepened its partnership with Sanofi, announcing an expansion of Sanofi’s license to include the use of Matrix-M® adjuvant in Sanofi’s pandemic influenza vaccine candidate program, supported by recent BARDA funding.
Read more: ir.novavax.com/press-releases/2025-09-30-Novavax-Announce… -
Novavax
@Novavax
#news: Our COVID-19 vaccine is now approved in Japan for individuals aged 6 and older.
Learn more: ir.novavax.com/press-releases/2025-09-04-Nuvaxovid-R-Now-… -
Novavax
@Novavax
The 2025-2026 formulation of our COVID-19 vaccine is approved for use in individuals 65 years and older, or 12 years through 64 years of age with at least one underlying condition that puts them at high risk for severe outcomes from COVID-19. ir.novavax.com/press-releases/2025-08-27-Novavaxs-Nuvaxov…
-
Novavax
@Novavax
#news: Novavax announced the U.S. Food and Drug Administration (@FDA) has approved the Company’s Biologics License Application for its COVID-19 vaccine, Nuvaxovid™, triggering a Sanofi milestone payment.
Read the news release: ir.novavax.com/press-releases/2025-05-19-U-S-FDA-Approves… -
Novavax
@Novavax
#statement: Novavax responded to the formal communication request for a postmarketing commitment received from the U.S. Food and Drug Administration (FDA) for our Biologics License Application (BLA). Read more:
ir.novavax.com/press-releases/Latest-update-on-U-S-FDA-BL… -
Novavax
@Novavax
#statement: We have received formal communication from the U.S. Food and Drug Administration (FDA) about the Novavax COVID-19 vaccine Biologics License Application (BLA). Read more: ir.novavax.com/press-releases/Latest-update-on-U-S-FDA-BL…
-
Novavax
@Novavax
At this year’s #escmid Congress, we presented new real-world data from the SHIELD-Utah study conducted in partnership with the University of Utah Health
Read more about the findings: ir.novavax.com/press-releases/2025-04-15-SHIELD-Utah-Stud… -
Novavax
@Novavax
An update on the status of Novavax’s COVID-19 Vaccine BLA
-
Novavax
@Novavax
We have a clear corporate growth strategy and many near-term milestones to look forward to in 2025.
Read more: novav.ax/4fZDoJO -
Novavax
@Novavax
We are focused on driving vaccine innovation to tackle global health challenges and create value for
our stakeholders through R&D and additional partnerships.
Read more: novav.ax/3Ccm4Ui -
Novavax
@Novavax
Novavax’s corporate growth strategy includes four core value drivers:
🔷 Executing on current partnerships
🔷 Advancing our late-stage pipeline
🔷 Driving additional partnerships and deals through our technology
🔷 Building a robust early-stage pipeline.
Learn more: -
Novavax
@Novavax
We are excited to be in San Francisco this week and share how Novavax is executing against our new corporate growth strategy, focused on delivering value through R&D and partnerships.
To learn more about how we’re reshaping our future, click here: novav.ax/40e9Kek -
Novavax
@Novavax
We’re excited to be in San Francisco this week having meaningful conversations and sharing our vision for our new corporate growth strategy. Key to this is our technology platform. When combined with our deep vaccine expertise, it fuels innovation and partnerships that can impact global health.
Read more: novavax.widen.net/s/wggdm8jtjb/novavax-jan-2025-corporate… -
Novavax
@Novavax
We’re excited to share more about our corporate strategy and how we’re focused on harnessing the promise of vaccine innovation to improve global health. Read more about our new approach to R&D and strategic partnerships in this article novav.ax/3E3N3Sn and our presentation novav.ax/4hcOhJn
-
Novavax
@Novavax
Our science has been featured in several new publications. Learn more about our research: medical.novavax.com/publications-posters-presentations
#medicalprofessionals #scientificcommunity -
Novavax
@Novavax
Novavax’s corporate growth strategy includes efforts to pursue additional partnerships for its late-stage and early-stage Research and Development assets and Matrix-M™ adjuvant alone.
This growth strategy should position the Company for ongoing value creation, as additional partnerships are secured under a similar contractual framework, and broaden global access to our vaccine technology and the protections it can provide.
Read the press release at: ir.novavax.com/press-releases/2024-12-13-Novavax-Advances… -
Novavax
@Novavax
Novavax advances its corporate growth strategy through Sanofi partnership with achievement of first $50 million milestone.
Read the press release at: novav.ax/41xqFuj -
Novavax
@Novavax
#news: Novavax today announced it has achieved a milestone associated with its Phase 2/3 clinical trial for its #covid19 vaccine in children, triggering the first $50 million milestone payment from Sanofi.
Read the press release: novav.ax/4g9qc6f -
Novavax
@Novavax
#news: Novavax initiates its COVID-19-Influenza Combination and stand-alone influenza Phase 3 trial.
Read the press release at: novav.ax/49CFON5 -
Novavax
@Novavax
#news: Novavax sells its manufacturing facility in the Czech Republic to Novo Nordisk for $200 million.
Read the press release at: novav.ax/4f0mlam -
Novavax
@Novavax
Targeting JN.1, the current "tree trunk," potentially increases the breadth of crossprotection against emerging strains in light of the possibility that future dominant JN.1-descendant strains may not be descendants of KP subvariants.
Learn more here: www.novavax.com/insights/value-targeting-jn1-tree-trunk -
Novavax
@Novavax
This week, Novavax is attending the 2024 @Jefferies London Healthcare Conference!
Watch the live webcast here (available for 30 days): ir.novavax.com/events/novavax-participate-jefferies-londo… -
Novavax
@Novavax
Viruses evolve. It’s the reason healthcare providers recommend getting updated flu and COVID-19 shots this respiratory virus season. Do you plan to get an updated vaccine?
Learn more about the value of targeting the JN.1 strain: www.novavax.com/insights/value-targeting-jn1-tree-trunk -
Novavax
@Novavax
Our new corporate growth strategy is focused on driving future value from additional business development activities AND organic research and development using our proven technology.
Read our full Q3 2024 financial results and operational highlights: novav.ax/3CAJv9q -
Novavax
@Novavax
Novavax continues to advance our new corporate growth strategy focused on driving future value from additional business development activities AND organic research and development using our proven technology. Read our full Q3 2024 financial results and operational highlights:
-
Novavax
@Novavax
TODAY at 8:30 a.m. ET is the third quarter 2024 Novavax conference call to discuss financial results and operational highlights. Learn how you can join: novav.ax/4fjdwcy
-
Novavax
@Novavax
The R21/Matrix-M™ malaria vaccine, which targets the malaria antigen R21 and includes Novavax’s unique Matrix-M adjuvant, has been named "A Game-Changing Vaccine" as part of @TIME Best Inventions of 2024 in the Social Good category.
We are grateful for this recognition and look forward to extending the use of Matrix-M in more life-saving applications.
Learn more: time.com/7094916/university-of-oxford-and-the-serum-insti… -
Novavax
@Novavax
Novavax's conference call to discuss third-quarter 2024 financial results and operational highlights is November 12 at 8:30 a.m. ET. Learn how you can join: novav.ax/3AEkXMa
-
Novavax
@Novavax
As we focus on driving value via our proven technology through partnerships and R&D, Åsa and our AB site will be critical to ensuring robust supply of our best-in-class Matrix-M™ adjuvant for both our pipeline and potential partners.
Read the press release:
novav.ax/48QvqkF -
Novavax
@Novavax
This season, Novavax and the @Commpharmacy are joining forces to help educate the public about COVID-19 vaccination.
Tune into this @NTVNEWS segment to learn more about COVID-19 and the value of vaccination: nebraska.tv/features/ntvs-good-life/covid-19-has-not-gone… -
Novavax
@Novavax
Targeting the JN.1 “tree trunk” can help protect against COVID-19. Do you plan to get vaccinated?
Learn more about the value of targeting the JN.1 strain: www.novavax.com/insights/value-targeting-jn1-tree-trunk -
Novavax
@Novavax
The U.S. CDC Advisory Committee on Immunization Practices has recommended an additional COVID-19 vaccine dose for older individuals and those who are immunocompromised.
ir.novavax.com/press-releases/U-S-CDC-and-ACIP-Recommend-… -
Novavax
@Novavax
Novavax is excited to attend this year’s annual @IDWeekmtg in Los Angeles. Our #supernovas look forward to connecting and learning from experts in patient care and public health.
Learn more about this event: idweek.org -
Novavax
@Novavax
Today is #nationalpharmacytechnicianday! Novavax celebrates all the hard-working pharmacy technicians and their dedication to public health.
Visit your friendly neighborhood pharmacy team and learn about your options to help protect yourself this season. -
Novavax
@Novavax
Congratulations to our EVP, Chief Corporate Affairs and Advocacy Officer, Silvia Taylor, for being recognized on the 2024 @PharmaVoice 100 list as an inspiring leader in life sciences!
Read more: www.pharmavoice.com/news/pv100-pharma-leaders-executives/…
#pharmavoice100 #pharmaleaders -
Novavax
@Novavax
The best source for finding Novavax’s #covid19 vaccine is novav.ax/3zJInj5. Not every vaccine finder may have the most up to date information.
Learn more: novav.ax/3ZVh7bZ
*For U.S. audience only -
Novavax
@Novavax
Novavax and the National Community Pharmacists Association (@Commpharmacy) joined forces to help educate the public about COVID-19 and vaccination this season.
Learn more about Novavax: www.novavax.com -
Novavax
@Novavax
The @European Commission has granted authorization for our updated #covid19 vaccine in individuals aged 12 and older in the European Union to protect against currently circulating variants.
Read the press release: novav.ax/47X5IKL -
Novavax
@Novavax
Executive Director of Clinical Development, Chijioke Bennett, MD, MPH, MBA, will be a panelist at the Maryland Tech Council Bio Innovation Conference on October 10th. Learn more: www.marylandlifesciences.com/conference/
-
Novavax
@Novavax
Today is the first day of #nationalphysicianassistantsweek! Thank you to all the public health heroes that help keep our communities safe.
-
Novavax
@Novavax
We are proud members of the vibrant Maryland community!
We’re thankful to organizers County Executive @MontCoExec and Council Member @CMKristinMink, as well as Council Members @albornoz_gabe, @MC_Council_Katz, and @dawn_luedtke, Johnny Dorsey from Governor Moore’s office, @GiantFood officials and the many civic and local health leaders that came together to emphasize the importance of vaccination this season.
#getvaccinated #covid19 #respiratoryvirusseason -
Novavax
@Novavax
Help protect yourself this season: www.novavax.com
-
Novavax
@Novavax
Fall has arrived! With temperatures cooling, autumn activities are in full swing. Make sure you're staying up-to-date on vaccines. www.novavax.com
-
Novavax
@Novavax
At Novavax, we recognize the vital role pharmacists and their teams play in communities around the world promoting public health and wellness. Join us in saying thank you this #worldpharmacistday!
Learn more: www.novavax.com/insights/celebrating-impact-pharmacists-t… -
Novavax
@Novavax
We are excited to announce that Ruxandra Draghia-Akli, MD, PhD, will join Novavax in November 2024 as Executive Vice President and Head of Research & Development (R&D).
Learn more: ir.novavax.com/press-releases/2024-09-25-Novavax-Names-Dr… -
Novavax
@Novavax
The updated Novavax COVID-19 vaccine is now available in thousands of locations across the US. Use our interactive map - which is updated with locations regularly – to see where doses are stocked: us.novavaxcovidvaccine.com/vaccine-finder
-
Novavax
@Novavax
We are proud to share that our COVID-19 vaccine is expected to be available at thousands of locations across major retail pharmacies in the U.S., including @cvspharmacy, @riteaid, @Walgreens, @Costco, @SamsClub, @Walmart, @kroger, @meijer, and @Publix.
Find a Novavax vaccine near you: us.novavaxcovidvaccine.com
Link to press release: novav.ax/3XELWzY -
Novavax
@Novavax
Novavax continues to monitor the performance of our 2024-2025 formula COVID-19 vaccine against new variants in non-clinical studies.
Our data indicate that our vaccine provides cross-reactivity against the currently circulating variants. -
Novavax
@Novavax
During the second quarter, Novavax continued executing against its four key priorities for the remainder of 2024. Take a look at our second quarter 2024 financial results and operational highlights: ir.novavax.com/press-releases/2024-08-08-Novavax-Reports-…
-
Novavax
@Novavax
Novavax's conference call to discuss second quarter 2024 financial results and operational highlights is starting at 8:30 a.m. ET. Learn how you can join the call: ir.novavax.com/events
-
Novavax
@Novavax
August is National Immunization Awareness Month! Here at Novavax, our focus is on developing life-saving vaccines to fight infectious diseases. Take the @CDCgov adult vaccines quiz to learn more about what is recommended to protect you: www2.cdc.gov/nip/adultimmsched/
#niam #vaccineswork -
Novavax
@Novavax
Novavax's conference call to discuss second quarter 2024 financial results and operational highlights is August 8 at 8:30 a.m. ET. Learn how you can join the call: ir.novavax.com/press-releases/2024-08-01-Novavax-to-Host-…
-
Novavax
@Novavax
“We need to rebuild confidence in the value and significance of a #covid vaccine.” -Novavax President and COO, @jtrizzino.
Novavax was honored to attend @PremierHA’s Breakthroughs ‘24 last week to discuss the future of vaccination. Thank you to all who joined!
Learn more about Novavax here: www.novavax.com -
Novavax
@Novavax
We are proud to share Novavax’s participation in @Citeline 's Navigating Clinical Trial Success: Biotech Lessons Learned roundtable. Learn from our Vice President of Clinical Development, Dr. Vivek Shinde, and other experts featured in the publication: discover.pharmaignite.com/novotech-us-rt-report
-
Novavax
@Novavax
At Novavax, we're collaborating to help build a future free from the grip of malaria. Learn more: www.novavax.com/insights/collaborating-future-free-grip-m…
-
Novavax
@Novavax
Novavax President and COO @jtrizzino will be interviewed by @PremierHA's Chief Commercial Officer Andy Brailo during Premier’s Breakthroughs '24 conference.
-
Novavax
@Novavax
For the first time, two vaccines are available to help protect children against malaria, which kills more than 600,000 people each year, 80% of whom are children under the age of 5.
Learn more: www.novavax.com/insights/collaborating-future-free-grip-m… -
Novavax
@Novavax
R21/Matrix-M™ Malaria vaccine administration expands: South Sudan has begun vaccinating eligible children to help protect against malaria as part of a 4-dose series. Learn more: www.gavi.org/news/media-room/south-sudan-launches-r21-mal…
-
Novavax
@Novavax
Malaria is one of the deadliest diseases in history and so common that a child under five years of age dies from malaria nearly every minute of every day.
Learn more: www.novavax.com/insights/collaborating-future-free-grip-m… -
Novavax
@Novavax
Yesterday, the first commercial doses of the R21/Matrix-M™ malaria vaccine were administered to children in Cote d’Ivoire after decades of work by many developers and collaborators. Novavax celebrates this moment while noting there is much work ahead to curb the impact of malaria.
Read the full statement: www.ox.ac.uk/news/2024-07-15-c-te-d-ivoire-makes-history-… @SerumInstIndia @UniofOxford -
Novavax
@Novavax
Today, the first-ever doses of R21/Matrix-M™ Malaria Vaccine outside a clinical trial were administered in Cote d’Ivoire. We are both joyful at this milestone and hopeful for its potential to curb the impact of the disease. Congratulations to our partners and all involved in this achievement: @UNICEF, @Gavi, @WHO, @UniofOxford, and @SerumInstIndia.
Learn more: www.ox.ac.uk/news/2024-07-15-c-te-d-ivoire-makes-history-… -
Novavax
@Novavax
Today the U.S. Advisory Committee on Immunization Practices recommended use of 2024-2025 Formula for COVID-19 vaccines.
Read the statement at: ir.novavax.com/press-releases/U-S-ACIP-Recommends-Use-of-… -
Novavax
@Novavax
Novavax has filed with the European Medicines Agency (EMA) for its updated COVID-19 vaccine. Read more: novavax.investorroom.com/2024-06-24-Novavax-Submits-Appli…
-
Novavax
@Novavax
Novavax is attending the 2024 AANP National Conference in Nashville, TN this week! We look forward to connecting with the @AANP_NEWS community.
-
Novavax
@Novavax
Novavax has submitted its application to the U.S. FDA for its updated COVID-19 vaccine.
Read more: ir.novavax.com/press-releases/2024-06-14-Novavax-Submits-… -
Novavax
@Novavax
Novavax recognizes the vital role adult vaccination plays in helping protect public health. A recently published study by @OHENews finds that adult vaccines return the equivalent of billions of dollars to society. Learn more about the health and socio-economic benefits of adult vaccination programs: www.ifpma.org/initiatives/vaccinesforlife @IFPMA #vaccinesforlife #healthforall
-
Novavax
@Novavax
Novavax is proud of our sustainable supply chain. Saponin, a critical component of our Matrix-M™ adjuvant, is purified from the bark of the Quillaja saponaria Molina tree and is sustainably harvested to reduce deforestation.
Read more: www.novavax.com/who-we-are/our-commitments/environmental-… -
Novavax
@Novavax
TODAY: John Jacobs, our President and Chief Executive Officer, is participating in a Fireside Chat at the 2024 @Jefferies Global Healthcare Conference. Learn more: wsw.com/webcast/jeff302/nvax/1864016 #jefferieshealthcare
-
Novavax
@Novavax
#breaking: @US_FDA VRBPAC recommends JN.1 #covid19 vaccines.
Novavax is ready to help. Read more: novavax.investorroom.com/Novavax-Prepared-to-Deliver-JN-1… -
Novavax
@Novavax
Novavax is proud of our diverse workforce. In the U.S. 54% of our employees are women. Our R&D team is 67% female.
Read more in the Novavax Environmental, Social and Governance 2023 Report: www.novavax.com/who-we-are/our-commitments/environmental-… -
Novavax
@Novavax
Misinformation and distrust in science and medicine aren't only about vaccines and #covid-19. Tomorrow, Novavax will moderate a lively panel dedicated to sharing actionable strategies to improve trust & equity in health information. Join us at 3:00 pm in Room 30 DE. #bio2024 @IAmBiotech
Novavax
@Novavax
TODAY: Don't miss "Vaccinating Against Mistrust and Misinformation During an Infodemic."
Novavax will lead a discussion with Dr. Reed Tuckson, Miriam Mason, and Pedro Martinez, MPH on closing the gap between health guidance and the public's behavior at #bio2024. @IAmBiotech -
Novavax
@Novavax
Novavax is proud of the forward momentum we are making across four strategic ESG pillars. We believe that what we do is just as important as how we do it.
Read more in the Novavax Environmental, Social and Governance 2023 Report: www.novavax.com/who-we-are/our-commitments/environmental-… -
Novavax
@Novavax
Novavax is participating in the 2024 @Jefferies Global Healthcare Conference in New York, NY this week! We look forward to discussing the future of Novavax and exploring trends driving health care in the U.S. and internationally. John Jacobs, our President and Chief Executive Officer, is participating in a Fireside Chat on June 6th. Learn more: ir.novavax.com/press-releases/2024-05-30-Novavax-to-Parti… #jefferieshealthcare
-
Novavax
@Novavax
A new study from @OHENews highlights the socio-economic impact of adult vaccination and shows these vaccines can return up to 19 times their initial investment to society. Novavax joins global stakeholders in recognizing the benefit adult vaccination programs have on our health systems and economies: www.ifpma.org/initiatives/vaccinesforlife @IFPMA #vaccinesforlife #healthforall
-
Novavax
@Novavax
TODAY: Join us for "Avoid the Cycle of Panic and Neglect: How Ongoing Commitment to Innovative Partnerships Futureproofs Against the Next Pandemic."
Novavax and leaders from USG, HERA, CEPI, and APHA will discuss approaches to pandemic preparedness at 4:15 pm in Room 29C. Don’t miss it! #bio2024. @IAmBiotech
Novavax
@Novavax
It is the responsibility of the scientific community to stay vigilant to help protect our global citizens from the next big outbreak. Tomorrow, find out how Novavax and other global leaders are preparing now for the next pandemic at #bio2024. @IAmBiotech
-
Novavax
@Novavax
It is the responsibility of the scientific community to stay vigilant to help protect our global citizens from the next big outbreak. Tomorrow, find out how Novavax and other global leaders are preparing now for the next pandemic at #bio2024. @IAmBiotech
-
Novavax
@Novavax
We are proud to share Novavax's involvement in @Citeline's Infectious Disease Clinical Trials: Navigating Innovation & Rising Complexity roundtable. Learn from our Senior Director of Clinical Development, Dr. Chijioke Bennett, and other experts featured in the publication: scrip.citeline.com/-/media/editorial/scrip/2024/05/cerba-…
-
Novavax
@Novavax
Novavax is excited to be participating in two panels at #bio2024 in San Diego, CA this week! Join us Monday and Wednesday for two engaging and timely vaccine and pandemic-related discussions with industry & government leaders.
Learn more about both sessions below:
convention.bio.org/sessions/avoid-cyle-panic-neglect-ongo…
convention.bio.org/sessions/vaccinating-against-mistrust-…
@IAmBiotech -
Novavax
@Novavax
Novavax is proud to join our partners in the launch of the COVID Transition Initiative. Please find the CTI's report and recommendations here www.covid-transition.com
-
Novavax
@Novavax
Ambassador Eric Garcetti @USAmbIndia, Novavax Executive Vice President, Chief Corporate Affairs and Advocacy Officer, Silvia Taylor, @SerumInstitute CEO, @adarpoonawalla, and other dignitaries commemorated the historic rollout of the R21/Matrix-M™ malaria vaccine at an event in India today.
-
Novavax
@Novavax
We are proud to announce that today, the first doses of the new R21/Matrix-M™ malaria vaccine were shipped by our partner @SerumInstIndia to Africa. Read our full announcement: ir.novavax.com/press-releases/First-Doses-of-R21-Matrix-M…
-
Novavax
@Novavax
Novavax is attending #espid2024 this week in Copenhagen. We look forward to a week of exciting data with the goal of promoting health and well-being in children. @ESPIDsociety
-
Novavax
@Novavax
Novavax is attending the Interdisciplinary Congress of Professionals in Geriatrics in Montpellier this week! We look forward to connecting with experts in elderly care and gerontology from across France
Novavax
@Novavax
Novavax participe cette semaine au Congrès Interdisciplinaire des Professionnels de la Gériatrie à Montpellier! Nous sommes impatients de rencontrer les experts en soins aux personnes âgées et en gérontologie de toute la France.
-
Novavax
@Novavax
Europe can continue to strengthen vaccine innovation and help protect public health with an #euimmunisationstrategy – Kelly Cappio, Vice President of Global Policy & Government Affairs at Novavax.
Learn more here from @VaccinesEurope: www.vaccineseurope.eu -
Novavax
@Novavax
TODAY: Listen at 8:30 a.m. ET for a conference call as we announce our first quarter 2024 financial results and operational highlights.
Press release: novav.ax/4akkri9
Join here: ir.novavax.com/events -
Novavax
@Novavax
This collaboration combines Novavax’s R&D expertise and proprietary Matrix-M™ technology with @sanofi's world-class leadership in launching and commercializing innovative vaccines.
Read the press release at: novav.ax/4dxQ3nu -
Novavax
@Novavax
Novavax's first quarter 2024 financial results and operational highlights conference call is Friday at 8:30 a.m. ET. Learn how you can join the call: ir.novavax.com/events
-
Novavax
@Novavax
Novavax is pleased to announce a publication in @biomedcentral. Learn more: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
On the last day of #worldimmunizationweek our Senior Director of Advocacy, North America, Mike Walsh, shares his perspective on the intersection of vaccines and advocacy. Visit www.who.int/campaigns/world-immunization-week/2024 and www.novavax.com/about-us to learn more. #vaccineswork @WHO
-
Novavax
@Novavax
In 2023, we delivered on important objectives to help move our company forward. Read about these accomplishments and more in our 2023 Annual Report: novavax.widen.net/s/x8hj2wfsww/2023-annual-report
-
Novavax
@Novavax
Novavax General Manager of Commercial Operations, Asia Pacific, Olivia Chua, reflects on vaccine progress and the path forward this #worldimmunizationweek. Visit www.who.int/campaigns/world-immunization-week/2024 and www.novavax.com/about-us to learn more. #vaccineswork @WHO
-
Novavax
@Novavax
Dr. Seth Toback, Senior Vice President of Global Medical Affairs at Novavax, will present on "Local and systemic reactogenicity after mRNA and protein-based #covid vaccines compared to meningococcal vaccine (MenACWY) in a UK blinded, randomised phase 2 trial (COV-BOOST)." #escmidglobal
Post not available here, view on X
Novavax
@Novavax
Dr. Vivek Shinde, Vice President of Clinical Development, will present "Investigational influenza vaccine and COVID-influenza combination vaccine development update," at the session titled "What's new in #influenza and #covid19 vaccination?" #escmidglobal
Novavax
@Novavax
Dr. Vivek Shinde, Vice President of Clinical Development, will return to present "Open-Label Study to Evaluate the Safety and Immunogenicity of an XBB.1.5 (Omicron Subvariant) CoV-2 rS Vaccine Booster in Previously mRNA #covid19 Vaccinated Participants."
#escmidglobal -
Novavax
@Novavax
Novavax is attending #escmidglobal in Barcelona this weekend! We're excited to participate in the foremost European congress on clinical microbiology and infection, and look forward to showcasing more of what our scientific platform is capable of through the sharing of new data. Will we see you there? @ESCMID
-
Novavax
@Novavax
This #worldimmunizationweek, Dr. Seth Toback, our Senior Vice President, Global Medical Affairs, is reminding us of the power of vaccines to protect public health. Visit www.who.int/campaigns/world-immunization-week/2024 and www.novavax.com/about-us to learn more. #vaccineswork @WHO
-
Novavax
@Novavax
Novavax celebrates the impact of vaccines in preventable diseases this #worldimmunizationweek! From the eradication of smallpox to the ongoing fight against #covid-19, to future advances in malaria and other serious diseases, we celebrate the role vaccines play in protecting public health. Learn more: global.novavax.com #vaccineswork @WHO
-
Novavax
@Novavax
Novavax is attending @ACPIMPhysicians's Internal Medicine Meeting in Boston, MA this week! We look forward to connecting with leaders in the internal medicine community. Will we see you there? #im2024 #masteringmedicinetogether
-
Novavax
@Novavax
Novavax is attending @RE_Pharma 2024 in Barcelona this week! We look forward to connecting with some of the world's leading pharmaceutical changemakers. #repharma2024
-
Novavax
@Novavax
Novavax is proud to announce a publication in Vaccine. Learn more: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Last week at @vaccinenation's 2024 World Vaccine Congress, Novavax’s Chief Medical Officer, Dr. Bob Walker, spoke about lessons learned from the COVID-19 pandemic and our path forward. Thank you to all who attended! #wvcdc
-
Novavax
@Novavax
Today is #worldhealthday! At Novavax, we never rest in our quest to protect the health of people everywhere. Learn more: www.novavax.com
-
Novavax
@Novavax
That's a wrap on @vaccinenation's World Vaccine Congress 2024! Novavax looks forward to continuing our quest to protect the health of people everywhere. Learn more about our science: www.novavax.com #wvcdc
-
Novavax
@Novavax
Today kicks off #nationalpublichealthweek! At Novavax, we're committed to advancing public health through our life-saving science. Thank you to all the healthcare professionals who work tirelessly to protect public health!
-
Novavax
@Novavax
TODAY: Don't miss the Novavax team at @vaccinenation's World Vaccine Congress 2024. #wvcdc
Post not available here, view on X -
Novavax
@Novavax
Novavax wishes you a happy Easter!🐰
-
Novavax
@Novavax
Happy National Doctors Day! Novavax is grateful for the dedication of doctors everywhere who help protect us from public health threats. #nationaldoctorsday
-
Novavax
@Novavax
Novavax is attending @vaccinenation's World Vaccine Congress 2024 next week in Washington, DC! We look forward to connecting with leaders in vaccine science. #wvcdc www.terrapinn.com/conference/world-vaccine-congress-washi…
-
Novavax
@Novavax
Kelly Cappio, our Vice President of Global Policy & Government Affairs, represented Novavax, the Corporate Host for @MeridianIntl's Global Business Briefing with @KarenPierceUK, British Ambassador to the United States, and @AMBSHolliday, to highlight the future of the U.S.-U.K. relationship and the importance of partnerships.
-
Novavax
@Novavax
Today is Holi! Novavax celebrates the life, love, unity, and friendship this vibrant festival represents. Happy Holi to all of you who celebrate.
-
Novavax
@Novavax
Today is National Certified Nurses Day! At Novavax, we recognize the crucial work of Certified Nurses in our healthcare system. Thank you for protecting public health!
-
Novavax
@Novavax
Happy St. Patrick's Day! Novavax wishes you the best of luck.🍀
-
Novavax
@Novavax
Today is National Vaccination Day! 💉 At Novavax, we're focused solely on developing life-saving vaccines to fight infectious diseases. Learn more about our science: www.novavax.com
-
Novavax
@Novavax
This Celebrate Scientists Day, we're acknowledging the #supernova scientists behind our innovative vaccines. Thank you for all you do! 🥼
-
Novavax
@Novavax
Novavax proudly sponsored @POLITICO’s annual Health Care Summit where leading voices in health care came together to discuss the future of medicine. Learn more about this event: www.politico.com/healthcaresummit2024
@POLITICOLive #politicohealth -
Novavax
@Novavax
Last week, Novavax attended the National COVID Summit in Valencia, Spain. We were honored to share invaluable knowledge & insights with experts in the industry. These important events are a reminder that protecting public health is a collective effort, and we look forward to the future of vaccine science. #ncs24
-
Novavax
@Novavax
Novavax is pleased to announce a publication in The Lancet Infectious Diseases. Learn more: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Canada’s National Advisory Committee on Immunization has published guidance on the use of our updated COVID-19 vaccine. This guidance helps support efforts to provide greater access, and could help achieve improved immunization rates.
Learn more: ir.novavax.com/press-releases/Canada-National-Advisory-Co… -
Novavax
@Novavax
Ramadan Mubarak to all who celebrate!
-
Novavax
@Novavax
Novavax is sponsoring the Patient Village at @PharmagoraPlus on March 9-10 in Paris, France.
We look forward to learning from leading pharmacists and healthcare professionals.
Learn more: www.pharmagoraplus.com/en
Novavax
@Novavax
Nous sommes ravis d'annoncer que Novavax est le sponsor officiel du Village-Patients de @PharmagoraPlus, qui se tiendra les 9 et 10 mars à Paris.
Cette collaboration représente pour nous une opportunité exceptionnelle d'échanger et d'apprendre auprès des pharmaciens et professionnels de santé leaders dans leur domaine.
Pour en savoir plus sur cet événement incontournable: www.pharmagoraplus.com -
Novavax
@Novavax
Novavax is committed to promoting equity in public health and the workplace. This #internationalwomensday, we're spotlighting some of the #supernova women who make our contribution to a safer world possible. Thank you for all you do!
-
Novavax
@Novavax
Novavax is proud to announce a new publication in Clinical Infectious Diseases. Read more here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
March is Expanding Girls' Horizons in Science and Engineering Month! At Novavax, our #supernovas are helping pave the way for future #womeninstem.
-
Novavax
@Novavax
Novavax is pleased to announce a publication in Vaccine. Read more here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Happy Women's History Month! This month we recognize and celebrate the monumental contributions that women scientists have made in vaccinology. Thank you to our #supernovas!
-
Novavax
@Novavax
Novavax President and CEO, John Jacobs, will participate in a Fireside Chat at @TDCowen’s 44th Annual Health Care Conference on March 6.
Learn more: ir.novavax.com/press-releases/2024-02-29-Novavax-to-Parti… #tdcowenhealthcare -
Novavax
@Novavax
Novavax is proud to announce a new publication in the Journal of Infection. Learn more here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
ACIP recommends an additional dose of a COVID-19 vaccine for persons 65 and older.
Learn more: ir.novavax.com/press-releases/Novavaxs-Protein-based-Non-… -
Novavax
@Novavax
Join us today at 8:30 a.m. EST for our fourth quarter and full year 2023 financial results and operational highlights.
Register here: emportal.ink/3SqJSJv
Read our Q4 earnings release: ir.novavax.com/press-releases/2024-02-28-Novavax-Reports-… -
Novavax
@Novavax
Novavax and Gavi, the Vaccine Alliance announced they have reached a settlement related to the 2021 Advance Purchase Agreement (APA). Read more: novav.ax/3T5e6C6
-
Novavax
@Novavax
On February 28, Novavax will report its fourth quarter and full year 2023 financial results and operational highlights. Learn how you can join: ir.novavax.com/press-releases/2024-02-20-Novavax-to-Host-…
-
Novavax
@Novavax
Happy Valentine's Day! 💗 Spread the love by prioritizing your health this month.
-
Novavax
@Novavax
It's the International Day of Women and Girls in Science! 🔬👩🔬🧪Shout out to all of our #supernova women who inspire the next generation of #womeninstem - celebrate yourself today! #idwgs
-
Novavax
@Novavax
Happy Lunar New Year! This year of the dragon 🐲 represents health, strength, and good fortune. Best wishes for the coming year!
-
Novavax
@Novavax
Did you know? The @CDCgov has published its 2024 Immunization Schedules, which summarize its child, adolescent, and adult vaccine recommendations. Learn more here: www.cdc.gov/vaccines/schedules/index.html
-
Novavax
@Novavax
Novavax is pleased to announce a new publication in the Journal of Virology. Read more here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Novavax is proud to announce a new publication in The Journal of Clinical Investigation. Learn more here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Today Novavax announced details about our continued transformation, which includes saying goodbye to colleagues. We are grateful for their hard work, dedication, and service to the organization and our mission to protect the health of people everywhere. novav.ax/3HJeHmt
-
Novavax
@Novavax
Our Chief Corporate Affairs & Advocacy Officer, @SilT2, and our President and COO, @jtrizzino, accepted the 2023 Tell Award on Novavax' behalf from @SwissAmbUSA, Jacques Pitteloud at the @SwissEmbassyUSA in Washington, DC.
Learn more: #novavaxswitzerland novavax.ch -
Novavax
@Novavax
Novavax is pleased to announce a new publication in Vaccines. View the paper here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Novavax is pleased to announce a new publication in @medrxivpreprint. View the paper here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
We recognize the vital role pharmacists, and their teams play in communities around the world in promoting public health and wellness. This #nationalpharmacistday, learn how we celebrate the impact of pharmacists: www.novavax.com/insights/celebrating-impact-pharmacists-t…
-
Novavax
@Novavax
Recently at the European Health Summit, our Senior Director, Policy & Government Affairs, Europe, Andrea Corazza, discussed the case for a diverse #covid19 vaccine portfolio alongside leaders from HERA, @OBShealth, and @europarl_en.
Learn more: vimeo.com/892592498 -
Novavax
@Novavax
Recently, Novavax sponsored @ILCUK's #futureofageing event in London, UK! We were excited to connect with UK experts and discuss opportunities to develop and implement solutions for living happier, healthier and more fulfilling lives.
Learn more- www.novavax.co.uk -
Novavax
@Novavax
The recent #covid pandemic has raised our awareness of the different types of vaccines available.
Learn more about the difference between protein-based and mRNA vaccines from our latest blog post: es.novavax.com/en/blogs-and-insights/whats-difference-bet… -
Novavax
@Novavax
Novavax is sponsoring the 10th Jubilee Conference of the Polish Vaccinology Society on December 8-9! We're excited to discuss the latest guidelines and trends in preventive vaccinations.
Learn more about Novavax Poland and our science: www.novavax.pl -
Novavax
@Novavax
COVID-19 cases and hospitalization rates increased across the U.S. and the EU in November. With the holiday season upon us, experts have reiterated that our best line of defense is vaccination with the latest vaccines.
Learn more: novav.ax/46OrhuK -
Novavax
@Novavax
Novavax is attending the XXII National Congress of the Italian Society of Infectious and Tropical Diseases #simit in Florence, Italy on December 3-6! We look forward to discussing the latest updates in infectious diseases.
Learn more about Novavax: www.novavax.it -
Novavax
@Novavax
Surges in #covid19 cases have appeared in the US, EU, and UK during the last three winter seasons. The @CDCgov predicts a similar pattern to last year, this year.
Learn more about how to protect yourself and your family this vaccination season: www.novavax.com -
Novavax
@Novavax
Why is a new flu vaccine needed every year? Learn about how annual vaccinations protect us from new variants of the flu: www.novavax.de/en/blogs-and-insights/why-seasonal-influen…
-
Novavax
@Novavax
The flu vaccine must be regularly updated to target the specific virus strain that is predicted to be the dominant strain in circulation each year. Who makes this prediction, and how do they do it?
Learn more from our latest blog: www.novavax.it/en/blogs-and-insights/what-makes-influenza… -
Novavax
@Novavax
Novavax is pleased to announce a new publication in The Journal of Infectious Diseases. View the paper here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Novavax’s updated protein-based #covid19 #vaccine now an option for all 194 member states of the @WHO.
To read more: ir.novavax.com/press-releases/2023-11-28-Novavaxs-Updated…
#publichealth -
Novavax
@Novavax
Thank you to everyone who joined us at the @C_L_C_I Summit! Learn more about Novavax Spain and our science: es.novavax.com
#novavaxeurope #novavaxspain -
Novavax
@Novavax
Happy Thanksgiving from all of us at Novavax! 🦃 We're thankful for our #supernovas that make our science possible.
-
Novavax
@Novavax
Novavax is attending @C_L_C_I Summit in Almeria, Spain November 22-24. We look forward to connecting with other industry experts to discuss our dedication to protecting Europe from vaccine-preventable diseases.
Learn more about Novavax Spain: es.novavax.com -
Novavax
@Novavax
Novavax is proud to support the National Medical Association and blackdoctor.org working together to educate the public about the continuing threat of #covid19. Join Dr. Chijioke Bennett, and a panel of experts #today, November 20, at 7:00pm on facebook.com/blackdoctor.org/live.
-
Novavax
@Novavax
Novavax is pleased to announce a new #publication in The Journal of Infectious Diseases.
View the paper here: medical.novavax.com/publications-posters-presentations -
Novavax
@Novavax
Today, Novavax announced changes to its Executive Leadership Team.
Learn more: ir.novavax.com/press-releases/2023-11-17-Novavax-Makes-Ch… -
Novavax
@Novavax
Novavax is attending the Diabetes Autumn Conference in Leipzig, Germany on November 17-18! We look forward to hearing from industry leaders and discussing the importance of linking nutritional medicine and diabetology for the benefit of patients.
novavax.de -
Novavax
@Novavax
Yesterday, Novavax hosted ‘How We Manufacture Matrix-M’ on the occasion of the 10th anniversary of Novavax AB at our facility in Uppsala, Sweden! During the event, we showcased the innovative technology that makes our science possible.
Learn more: www.novavax.se/en -
Novavax
@Novavax
We are proud to announce that Novavax has won a 2023 Tell Award, which is presented annually to American companies that have invested in Switzerland. We look forward to increasing our impact in Europe!
Learn more: www.prnewswire.com/news-releases/novavax-and-ra-miller-in… -
Novavax
@Novavax
Novavax is participating in the @Jefferies London Healthcare Conference. Please join John C Jacobs, CEO and President, Jim Kelly, EVP and CFO, and Filip Dubovsky, M.D., President, R&D, in a fireside chat.
#jefferieshealthcare
Webcast Link: wsw.com/webcast/jeff287/nvax/1879724 -
Novavax
@Novavax
We recognize the vital role pharmacists and their teams play in communities around the world promoting public health and wellness.
Read more: www.novavax.com/insights/celebrating-impact-pharmacists-t… -
Novavax
@Novavax
Join Lucie Kutikova, Jonas Lundkvist, and Chengbin Wang, as they present at #isporeurope 2023.
Learn more: www.ispor.org/conferences-education/conferences/upcoming-… -
Novavax
@Novavax
Join Matt Rousculp, Vice President, Real World Evidence, as he presents at #isporeurope 2023 on November 13 from 10:30-13:30 UTC.
Learn more: www.ispor.org/conferences-education/conferences/upcoming-…
#isporeurope #novavaxeurope #announcement -
Novavax
@Novavax
Novavax is attending @ISPORorg Europe 2023 on November 12-15 in Copenhagen, Denmark! We look forward to hearing from experts on the role of health economics and outcomes research (HEOR) and how it shapes policy.
Learn more: www.ispor.org/conferences-education/conferences/upcoming-… -
Novavax
@Novavax
On this #veteransday, Novavax honors our nation’s Veteran’s, and the outstanding support @BlueStarFamily provides to them, every day of the year! #grateful
-
Novavax
@Novavax
Novavax is pleased to announce new publications in Scientific Reports and Frontiers in Drug Delivery. View papers here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Novavax is attending the 39th Pulmonology Congress in Algarve, Portugal on November 9-11! We look forward to learning alongside leaders in pulmonology.
Learn more about Novavax Portugal: novavax.pt
#novavaxeurope #novavaxportugal #announcement -
Novavax
@Novavax
Don't miss out on the poster presentation from Matt Rousculp, Vice President, Real World Evidence, at the Asian Vaccine Conference!
Learn more: asianvaccine.com -
Novavax
@Novavax
Join us today at 8:30 a.m. EDT for our third quarter 2023 financial results and operational highlights conference call.
Webcast details: novav.ax/3ufKHef
Recap: novav.ax/49uELhD -
Novavax
@Novavax
Novavax is attending the XII Congress of the @AEV_Vacunas on November 9-11 in Palma de Mallorca, Spain! We look forward to discussing the importance of getting vaccinated with industry experts.
Learn more about Novavax Spain: es.novavax.com -
Novavax
@Novavax
Matt Rousculp, Vice President, Real World Evidence, and Senior Vice President, Global Medical Lead, Seth Toback, MD, MMM, are presenting at the Asian Vaccine Conference!
Learn more: asianvaccine.com -
Novavax
@Novavax
Paul McIntosh, our UK & Ireland Country Director, and @JOCWhite, our Director of Government Affairs for the UK, Ireland, and the Nordics, attended the @NewStatesman's Future of Healthcare conference to discuss the importance of industry collaboration and continued focus on #covid
-
Novavax
@Novavax
Novavax will report its third quarter 2023 financial results and operational highlights at 8:30 a.m. EST on Thursday, November 9, 2023.
Details can be located: ir.novavax.com/press-releases/2023-11-02-Novavax-to-Host-… -
Novavax
@Novavax
Our Executive Vice President, Chief Corporate Affairs and Advocacy Officer, @SilT2, attended @LivePOLITICO's #politicohealthcare Summit alongside industry experts to discuss the importance of vaccine options. Learn more here: www.politico.eu/healthcare-summit/
-
Novavax
@Novavax
Attending the International Conference on Vaccine Research and Development? Join Chijioke Bennett, Senior Director, Clinical Development, today at 5:10 p.m. EST to hear about our Phase 3 trial comparing updated and prototype #covid19 vaccines.
vaccines.unitedscientificgroup.org/about -
Novavax
@Novavax
The @EU_Commission has approved our updated protein-based non-mRNA #covid19 vaccine in the European Union.
Read more about the approval: ir.novavax.com/press-releases/2023-10-31-Novavaxs-Updated… -
Novavax
@Novavax
Novavax is attending @apaciasia1 in Singapore on November 2nd! We look forward to hearing from experts, researchers, and healthcare providers about the latest advancements and challenges in respiratory health.
Learn more: www.novavax.com.sg
#novavaxapac -
Novavax
@Novavax
The @EU_Commission has approved our updated protein-based non-mRNA #covid19 vaccine in the European Union.
Read more about the approval: ir.novavax.com/press-releases/2023-10-31-Novavaxs-Updated… -
Novavax
@Novavax
Today, the @EMA_News #chmp recommended for approval our updated protein-based non-mRNA #covid19 vaccine in the European Union to protect against emerging variants.
Learn more: novav.ax/3tTCNY7 -
Novavax
@Novavax
Novavax is attending the 1st @APIC_NUS Summit on Infectious Diseases and Immunization October 31st and November 1st in Singapore! We look forward to hearing from industry leaders about the importance of vaccine equity and confidence. #novavaxapac
www.novavax.com.sg -
Novavax
@Novavax
This season, we’re helping families in the U.S. understand their #covid vaccine options to help protect themselves and their loved ones.
Learn how you can help #choosetoprotect against COVID: novav.ax/45pnsLC -
Novavax
@Novavax
Novavax is attending the American Academy of Family Physicians Congress of Delegates. We look forward to working alongside other industry leaders to discuss policies that will help family physicians. #aafpfmx
Learn more: www.aafp.org/about/congress-delegates.html -
Novavax
@Novavax
Novavax is attending the National Congress of Public Health on October 25 in Porto, Portugal! Learn more about Novavax Portugal: www.novavax.pt
#novavaxeurope #updates -
Novavax
@Novavax
Novavax is attending the 2023 International Society for Vaccines Annual Congress on October 22-24 in Lausanne, Switzerland! We're looking forward to discussing the latest in vaccines and immunotherapies with industry leaders. www.novavax.ch
-
Novavax
@Novavax
At World Vaccine Congress, we’re engaged in conversations about today's most important variants. #wvceu #novavaxeurope
Learn more about Novavax Spain: es.novavax.com
Learn more about the congress: www.terrapinn.com/conference/world-vaccine-congress-europ… -
Novavax
@Novavax
We are pleased to announce the launch #thevoicesofcovid website to serve as a centralized resource for Americans to find credible #covid19 information coupled with peer-peer relatable stories about the total impact COVID continues to have on our lives. www.thevoicesofcovid.com
-
Novavax
@Novavax
We’re headed to DC for @aapexperience National Conference and Exhibition!
What COVID-19 vaccination issues matter to #aap2023 attendees this fall? Weigh into the poll below. -
Novavax
@Novavax
BREAKING NEWS: We received full approval for our prototype #covid19 #vaccine in the United Kingdom via the Medicines and Healthcare products Regulatory Agency @MHRAgovuk.
Learn more: ir.novavax.com/press-releases/2023-10-18-Novavax-Receives… -
Novavax
@Novavax
BREAKING NEWS: We received full approval from Singapore’s Health Science Authority for our prototype #covid19 vaccine.
Learn more: ir.novavax.com/press-releases/2023-10-18-Novavaxs-Prototy… -
Novavax
@Novavax
As we conclude another #idweek, we reflect on the collective imperative from #covid19 experts to remain diligent in the face of new variants. #idweek2023 idweek.org
-
Novavax
@Novavax
Novavax is attending @vaccinenation #wvceu on October 16-19 in Barcelona, Spain!
We look forward to hearing from the leading voices in vaccine development and technology. Learn more about Novavax Spain: es.www.novavax.com
#novavaxeurope #updates -
Novavax
@Novavax
Doses of our protein-based non-mRNA #covid19 vaccine are now available at major retail pharmacies across the U.S.
To find a Novavax vaccine near you, please visit: us.novavaxcovidvaccine.com
To learn more: novav.ax/USpharmacy -
Novavax
@Novavax
Recently, on September 21st, Swissmedic granted full marketing authorization for our #covid vaccine in Switzerland. #novavaxeurope
Learn more about Novavax Switzerland: www.novavax.ch -
Novavax
@Novavax
This #internationaldayofthegirl, we thank all our #supernova women for what they've done to further our science. When girls have equal chances and support, they can become leaders, entrepreneurs, scientists, and agents of positive change.
-
Novavax
@Novavax
Novavax to present data at both @IDWeekmtg 2023 and #wvc2023 @vaccinenation.
Learn more here: ir.novavax.com/press-releases/2023-10-11-Novavax-Advances… -
Novavax
@Novavax
NVX ✈️ BOS
Our Supernovas just touched down at #idweek2023. Our team is looking forward to important conversations about protecting Americans against the new variants. Stop by booth #1923. idweek.org -
Novavax
@Novavax
We’re thrilled to partner with @HealthyWomen and actor, mother, and business owner @nicolearip to launch #choosetoprotect, a campaign to drive awareness about #covid19 in the U.S.
Discover more about the campaign here: novav.ax/3Fcli7w -
Novavax
@Novavax
Happy Canadian Thanksgiving from all of us at Novavax! We're thankful for our Canadian team members, partners, and community. 🇨🇦
-
Novavax
@Novavax
Today, we're taking time to recognize the rich cultures, traditions, and contributions of Indigenous communities. Join us in honoring #indigenouspeoplesday.
-
Novavax
@Novavax
Novavax is proud to announce that we were honored with a Silver Stevie Award for Great Employers in the Pharmaceuticals category! We'd like to thank The Stevie® Awards for this honor and all of our #supernovas who make Novavax a remarkable place to work. www.novavax.com/careers
-
Novavax
@Novavax
Protein-based vaccines have been protecting people from all sorts of infectious diseases since the mid-1980s, but #dyk what a protein-based vaccine is?
Learn more here: www.novavax.com/insights/what-protein-based-vaccine. -
Novavax
@Novavax
Novavax 2023-2024 COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
Read more: ir.novavax.com/press-releases/2023-10-03-Novavax-2023-202… -
Novavax
@Novavax
The U.S. FDA has granted Emergency Use Authorization for Novavax’s COVID-19 vaccine, Adjuvanted (2023-2024 Formula) to prevent COVID-19 in individuals aged 12 and older.
-
Novavax
@Novavax
Earlier this month, Novavax sponsored @TheBlackCaucus's Leadership Reception and the Sojourner Truth Reception in Washington, DC. We applaud the continued efforts to ensure Americans' health and safety from vaccine-preventable diseases.
-
Novavax
@Novavax
#czechstatehoodday reinforces cultural identity, unity, and the values of courage and dignity. We commemorate this day and celebrate all of our Czech #supernovas.
-
Novavax
@Novavax
“I’ve already been vaccinated during the pandemic, so why do I need another shot?” Because viruses evolve and it is important that we keep our bodies trained and ready to fight off potential infection.
Learn why you should consider getting an updated vaccine this season: -
Novavax
@Novavax
Novavax is proud to support @Aging_Research's Heroes in Health 30th Anniversary Celebration on September 26! This event will celebrate collaboration, integrity, and healthy aging. Learn more: www.agingresearch.org/events/2023heroesinhealth/
-
Novavax
@Novavax
Novavax is attending the 17th Vaccine Congress on September 24-27 in Glasgow, Scotland! We look forward to hearing leaders in the vaccination industry share their knowledge.
Learn more about Novavax UK: www.novavax.co.uk
#novavaxeurope #innovation #update -
Novavax
@Novavax
Please join Vivian Huang, as well as industry experts during a @Linkedin Live Panel Discussion hosted by @whywevax.
Click here to register and we will see you today at 12:00 PM. novav.ax/3rniSQg -
Novavax
@Novavax
Please join Novavax’s Chijioke Bennett, MD,
MPH MBA, and a panel of experts, as they discuss COVID 2.0, from Pandemic to Endemic, hosted by @blackdoctor_org
We’ll see you Wednesday, September 20, at 7pm.
www.facebook.com/BlackDoctor.org/live_videos/ -
Novavax
@Novavax
¡Gracias a todos! Thank you to everyone who attended #eswi2023! Learn more about Novavax Spain and our science: es.novavax.com
#novavax #eswi2023 -
Novavax
@Novavax
We had the pleasure of hosting members of the Montgomery County Government and the City of Gaithersburg at our Gaithersburg facility! Visitors gained insight into our science and the investment we're making in our community. www.novavax.com
-
Novavax
@Novavax
Please join Vivian H., Senior Medical Science Liaison, as well as industry experts during a @LinkedIn Live Panel Discussion, hosted by @WhyWeVax.
Click here to register! www.linkedin.com/uas/login?session_redirect=https%3A%2F%2… -
Novavax
@Novavax
The #covid19 emergency has passed but the virus remains a threat. The Novavax Sparrow Study is testing an updated #covid #vaccine for kids, using a traditional protein-based (not mRNA) approach. Enrollment now open for ages 12-17. Learn more: novavaxsparrowstudy.com
-
Novavax
@Novavax
Today, Novavax is attending @VizientInc Connections Summit in Las Vegas, NV. We are excited to share our story, and updates leading into the fall vaccination season. #vizientsummit2023
To learn more about Novavax, please visit us at novavax.com -
Novavax
@Novavax
Novavax's Alessandro Perretti, Lucie Kutikova, PhD, Maciej D. Zatonski will be presenting posters at @ESWInfluenza on Monday, September 18, between 7:30-9PM CEST. [2/2]
#eswi2023 -
Novavax
@Novavax
Join Seth Toback, MD, MMM, Matt Rousculp, Anthony Marchese, PhD, Vivek Shinde MD, MPH, as they present at @ESWInfluenza on Monday, September 18, between 7:30-9PM CEST. [1/2]
#eswi2023 -
Novavax
@Novavax
On #worldpatientsafetyday, we reaffirm our commitment to putting patients first. Through relentless innovation and unwavering standards, we strive for safer healthcare experiences. Together, we can create a healthier world.
#patientsafety #healthcareinnovation -
Novavax
@Novavax
Novavax is attending @ESWInfluenza on September 17-20 in Valencia, Spain! We look forward to hearing from scientists, public health experts, and healthcare professionals about the latest news in #influenza, #rsv, and #covid19. es.novavax.com
#eswi2023 -
Novavax
@Novavax
Happy Working Parents Day! Today, we applaud the incredible juggling act our working parents perform daily. Your dedication inspires us all. Here's to your remarkable balance and unwavering commitment.
#workingparentsday #parentingjugglingact -
Novavax
@Novavax
Celebrating Hispanic Heritage Month! We honor the rich history, vibrant cultures, and remarkable contributions of the Hispanic community. At Novavax, we put diversity and inclusivity at the forefront of our science.
#hispanicheritagemonth #diversitymatters -
Novavax
@Novavax
The @MinisteroSalute has published updated recommendations for a national #covid19 vaccine campaign stating that monovalent variant-adapted COVID-19 vaccines can be used as a booster this autumn and winter. www.novavax.it
#novavaxitaly #innovation #update -
Novavax
@Novavax
Novavax is proud to support the National Foundation for Infectious Diseases celebrating 50 years of education, prevention, and impact. We recognize the work of NFID and the inspirational public health heroes who protect the lives of millions.
www.nfid.org/education-events/nfid-50th-anniversary-gala/ -
Novavax
@Novavax
Happy 10th anniversary to our Novavax AB manufacturing site in Uppsala, Sweden! We thank our Novavax AB team for all their hard work advancing our science. Learn more: novav.ax/3EE9meC
#novavaxab #innovation #10thanniversary -
Novavax
@Novavax
The Novavax Sparrow #vaccine study is testing an updated, protein-based (non-mRNA) #covid19 shot. Hear from a pediatrician and see if your child qualifies. Now enrolling ages 12-17! novavaxsparrowstudy.com
-
Novavax
@Novavax
On European Heritage Day, we honor the rich tapestry of cultures that shape our biotech community. From diverse traditions to groundbreaking innovation, our shared heritage propels us forward. Proud to be a part of Europe's scientific legacy! #europeanheritageday
-
Novavax
@Novavax
U.S. CDC and Advisory Committee Recommend Use of Authorized and Approved 2023-2024 Monovalent XBB COVID-19 Vaccines
Read more: novav.ax/3sYvE87 -
Novavax
@Novavax
Novavax is part of groundbreaking non-mRNA #covid #vaccine research for kids. See if your child qualifies for the Sparrow Study. Now enrolling ages 12-17! novavaxsparrowstudy.com
-
Novavax
@Novavax
Doses of Novavax’s updated protein-based #covid vaccine arrived in the US today and will be ready for release pending EUA and recommendation from the @CDCgov and ACIP. Novavax will present the latest data on its vaccine at ACIP’s Sept.12, 2023 meeting. novav.ax/3PuRdGh
-
Novavax
@Novavax
Have an adolescent aged 12-17? Novavax is testing an updated #covid vaccine, using a protein-based (non-mRNA) technology. Participants are compensated for their time. Learn more: novavaxsparrowstudy.com
-
Novavax
@Novavax
We were honored to have various representatives from the Czech Republic tour our state-of-the-art manufacturing facility at Novavax CZ! During the tour, we were able to provide first-hand insight into our technology and investment in the Czech Republic. www.novavax.com
-
Novavax
@Novavax
Novavax has posted a pre-print for BioRxiv. View paper here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Happy Labor Day! Today, we honor the dedication and hard work of every individual that drives our company forward. Your relentless efforts inspire us daily. Here's to the achievements of our team!
-
Novavax
@Novavax
Novavax is pleased to announce a new publication in Vaccine. View paper here: medical.novavax.com/publications-posters-presentations
-
Novavax
@Novavax
Back-to-school season is just around the corner! Are you and your family up-to-date on all vaccinations? Learn more about Novavax: www.novavax.com.
-
Novavax
@Novavax
We honor Dr. Martha Dawson, outgoing President of the National Black Nurses Association (NBNA), for her outstanding contributions to nursing and welcome incoming President Dr. Sheldon D. Fields.
-
Novavax
@Novavax
This #womensequalityday, we want to recognize all of the inspiring #supernova women on our team. We couldn't develop our life-saving science without you! #womeninstem
-
Novavax
@Novavax
We're highlighting #supernova Rachael Gerlach, PhD, MPH, Sr. Director, Regulatory Affairs, as we count down to #womensequalityday. Read on to learn what being a woman in #stem means to her.
-
Novavax
@Novavax
In honor of #womensequalityday tomorrow, we're highlighting our #supernova Chiara Pesa, Informatics Analyst II. Learn what being a woman in #stem means to her.
-
Novavax
@Novavax
#womensequalityday is right around the corner. To celebrate, we're highlighting #supernova Susan Torrence, Human Resources Leader, and what being a woman in #stem means to her.
-
Novavax
@Novavax
Leading up to #womensequalityday, we're highlighting #supernova women at Novavax. Hear advice from Rashidah Daniel, Sr. Director, Supply Planning, for girls interested in pursuing careers in #stem.
-
Novavax
@Novavax
Novavax today announced that its updated protein-based XBB COVID vaccine candidate induced neutralizing antibody responses to the EG.5.1 and XBB.1.16.6 subvariants in small animal and non-human primate studies.
Learn more here: novav.ax/eg51 -
Novavax
@Novavax
In the days leading up to #womensequalityday, we're highlighting the #supernova women on our team. Hear from Kate Malachowski, Associate Director, MS&T, about what being a woman in #stem means to her.
-
Novavax
@Novavax
Have you voted? There is only a short time left to choose our @sxsw panel: A Post-Pandemic Playbook for Public-Private Partnerships! Vote here: panelpicker.sxsw.com/vote/134474
-
Novavax
@Novavax
August is #nationalimmunizationawarenessmonth. Are you up-to-date on vaccinations? Learn more: www.cdc.gov/vaccines/events/niam/index.html
-
Novavax
@Novavax
This weekend, Novavax is attending @NACDS Total Store Expo in San Diego, CA. We are excited to share our story, and updates leading into the fall vaccination season. To learn more about NACDS, or the Novavax Booth #1913, visit: tse.nacds.org.
#nacdstse #publichealth -
Novavax
@Novavax
Novavax was pleased to execute new agreements yesterday that build an enhanced strategic relationship with our partner @SKBioscience. We are looking forward to a productive partnership that benefits #globalhealth.
-
Novavax
@Novavax
Novavax is thrilled to announce the appointment of Mr. Ian Watkins as our new Chief Human Resources Officer. Together, we look forward to achieving new milestones and cultivating a workplace that nurtures excellence and empowers our people to thrive. www.novavax.com/who-we-are/leadership/ian-watkins
-
Novavax
@Novavax
Join us today at 8:30 a.m. EDT for our second quarter 2023 financial results and operational highlights conference call.
Details can be located: ir.novavax.com/press-releases/2023-08-08-Novavax-Reports-… -
Novavax
@Novavax
This #nationalimmunizationawarenessmonth, make sure you're protecting yourself and your loved ones from infectious diseases.
Learn more about Novavax: www.novavax.com -
Novavax
@Novavax
Novavax announced it will report its second quarter 2023 financial results and operational highlights at 8:30 a.m. Eastern Daylight Time (EDT) on Tuesday, August 8, 2023.
Details of the event and replay are as follows: ir.novavax.com/press-releases/2023-08-01-Novavax-to-Host-… -
Novavax
@Novavax
Happy Swiss National Day to our #supernova team in Switzerland! Thank you for being a part of our global team. 🌍
-
Novavax
@Novavax
Continuing to highlight our commitment to continuing research in areas of need, Novavax’s Global Medical Affairs team is presenting at @ASHMMedia.
-
Novavax
@Novavax
Congratulations to our partners for securing approval of R-21/Matrix-M™ malaria vaccine by Agence Nationale de la Regulation Pharmaceutique (ANRP) for use in children in Burkina Faso.
ir.novavax.com/press-releases/R21-Matrix-M-TM-Malaria-Vac… -
Novavax
@Novavax
Please remember to vote ahead of the upcoming Annual Meeting of Stockholders. Voting remains open until July 10, 2023, 11:59pm EST. Stockholders will need the control number they received via mail or email in order to vote.
Internet www.proxyvote.com
Phone 1-800-690-6903 -
Novavax
@Novavax
Novavax receives full Marketing Authorization in the EU for the prevention of #covid. Marketing Authorization replaces Conditional Marketing Authorization and is the first for Novavax in the EU.
novavax.investorroom.com/2023-07-06-Novavaxs-Nuvaxovid-TM… -
Novavax
@Novavax
On this special day, we honor the spirit of freedom and the countless individuals who have contributed to our nation's progress. As we celebrate our nation's independence, let us cherish the values that unite us: freedom, unity, and progress.
-
Novavax
@Novavax
While the @WHO has declared an end to the pandemic, we must remain vigilant. Our VP, Policy & Government Affairs, Kelly Cappio, shares three ways to bolster future responses to emerging infectious diseases and manage #covid19. Learn more: @VaccinesEurope novav.ax/vaccineseurope
-
Novavax
@Novavax
This week, Novavax executives co-hosted discussions in Stockholm and Berlin with @USAmbSweden and @USAmbGermany about how industry, policy makers, and regulators can work together to protect Europe’s most vulnerable citizens.
-
Novavax
@Novavax
We are grateful to those who made a positive impact during COVID-19. Inspire others with your story of courage here: thevoicesofcovid.com
-
Novavax
@Novavax
John C. Jacobs and @SilT2 spent the day on Capitol Hill meeting with congressional leaders to highlight Novavax’s contributions to the COVID vaccine landscape and the company’s intent to be in the U.S. market for the fall vaccination campaign. @ChrisVanHollen @brettguthrie
-
Novavax
@Novavax
The newest @rki_de #stiko update expands the recommendation for mRNA variant-adapted vaccines to include all licensed variant-adapted vaccines to be used as a booster this autumn season. www.novavax.de?sp_sn=linkedin&spclid=D2C8B2FC-C3F0-441B-9…
#covidvaccination -
Novavax
@Novavax
On this special day, we want to express our heartfelt gratitude to all the dedicated fathers in our #supernova community. Your commitment to your families and your incredible work ethic continue to inspire us all. #fathersday
-
Novavax
@Novavax
Novavax is prepared to deliver protein-based monovalent XBB COVID Vaccine Consistent with FDA VRBPAC recommendation for the fall ir.novavax.com/2023-06-15-Novavax-Prepared-to-Deliver-Pro…
-
Novavax
@Novavax
Novavax will participate in tomorrow’s #vrbpac meeting where the fall #covid19 vaccine strain will be decided.
Tune in at 8:30am ET to watch live: www.fda.gov/advisory-committees/advisory-committee-calend… -
Novavax
@Novavax
We’re excited to join the 28th Annual WONCA Congress and present our symposium on navigating the evolving #covid landscape: updates, challenges, and strategies for family doctors.
We will be at booth 22 – come and say hello! woncaeurope2023.gcon.me/page/home
#wonca2023 #biotech -
Novavax
@Novavax
Our Chief Corporate Affairs and Advocacy Officer @SilT2 shares Novavax’s journey to develop a diverse vaccine portfolio on the latest @HLTHEVENT Matters Podcast episode: hlth-matters.simplecast.com/episodes/s3-ep45-access-to-in…
-
Novavax
@Novavax
Dr. Henrietta Ukwu, EVP and Chief Regulatory Officer, experienced firsthand the impact that #covid19 had on the global regulatory landscape. The development of COVID-19 vaccines took the cooperation of multiple industries including regulatory authorities, governments and the private healthcare sector.
Learn more about the importance of this collaboration and its impact on regulatory pathways from STAT: www.statnews.com/sponsor/2023/04/27/regulatory-innovation…
#pharma #biotech -
Novavax
@Novavax
Novavax’s Dr. Henrietta Ukwu will be speaking at @IAmBiotech International Convention in #boston with industry leaders from @US_FDA and @EMA_News.
For more information on the event, visit www.bio.org/events/bio-international-convention
#bio2023 #pharma #regulatory #biotech #boston -
Novavax
@Novavax
Novavax Announces Agreement with Bill & Melinda Gates Medical Research Institute to Include Matrix-M™ Adjuvant as Potential Component in Vaccine Research.
For more information, visit: ir.novavax.com/2023-06-05-Novavax-Announces-Agreement-wit… -
Novavax
@Novavax
COVID-19 lit a fire under the global regulatory systems, triggering regulatory bodies and #pharma companies to prioritize and streamline their development efforts.
Novavax’s Dr. Henrietta Ukwu will be joining a panel discussion at #biointernationalconvention. -
Novavax
@Novavax
Today, all of us at Novavax would like to take a moment to remember and thank the service men and women who have made the ultimate sacrifice. #memorialday #gratitude #freedom
-
Novavax
@Novavax
Today we’re announcing a new press release on positive CHMP opinion. This post is intended for investors and media. Read more: ir.novavax.com/2023-05-26-Novavaxs-Nuvaxovid-TM-Receives-… #novavax #chmp
-
Novavax
@Novavax
Executive Vice President, Jill Hoyt, joined Andrew Jack from the @FinancialTimes in a panel to discuss innovation for long-term growth. See how Novavax is making changes in the culture to enhance creativity and productivity in #supernovas. #usphamaandbiotechsummit #ftpharma
-
Novavax
@Novavax
EVP, @SilT2, joined David Crow from the @FinancialTimes , to discuss data-driven engagement in the pharmaceutical industry. However, as tools evolve to help companies connect to their users, issues regarding privacy, regulation, and messaging arise. #uspharmaandbiotechsummit
-
Novavax
@Novavax
Novavax attended the 41st Annual @ESPIDsociety Congress in Lisbon, Portugal, alongside leaders in prenatal care, immunology, microbiology, and epidemiology. Were you there? #espid2023
-
Novavax
@Novavax
Today, John C. Jacobs, President & CEO and Filip Dubovsky, M.D., President, Research & Development will participate in the @BofA_News Securities 2023 Health Care Conference in Las Vegas, Nevada at 10 a.m (PDT).
Live stream details: bofa.veracast.com/webcasts/bofa/healthcare2023/idDR24lX.cfm -
Novavax
@Novavax
Positive Phase 2 Topline Results show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses.
See more: ir.novavax.com/2023-05-09-Positive-Phase-2-Topline-Result… -
Novavax
@Novavax
"Today we outlined significant measures intended to reduce spend, extend our cash runway, and operate more efficiently," said John C. Jacobs, President and CEO. ir.novavax.com/2023-05-09-Novavax-Reports-First-Quarter-2…
-
Novavax
@Novavax
Join us today at 8:30 a.m. EDT for our first quarter 2023 financial results and operational highlights conference call. Details can be located: ir.novavax.com/2023-05-02-Novavax-to-Host-Conference-Call…
-
Novavax
@Novavax
Novavax to Participate in the @BofA_News Securities 2023 Health Care Conference. Mark your calendars for May 11, 2023, 10-10:30 a.m PDT where John C. Jacobs, President and CEO and Filip Dubovsky, M.D., President, Research & Development will participate in a fireside chat.
-
Novavax
@Novavax
Novavax, Inc. (Nasdaq: NVAX), announced it will report its first quarter 2023 financial results and operational highlights at 8:30 a.m. EDT on Tuesday, May 9, 2023.
Details: ir.novavax.com/2023-05-02-Novavax-to-Host-Conference-Call… -
Novavax
@Novavax
The world urgently needs new tools to help solve some of our greatest infectious disease challenges. At Novavax, we're creating tomorrow's vaccines today. Learn more about Novavax #worldimmunizationweek: www.novavax.com/science-technology
-
Novavax
@Novavax
Did you know that other than access to clean water, vaccines have been the most influential factor on global health? Learn more about how we create our vaccines this #worldimmunizationweek: www.novavax.com/insights/how-novavax-vaccine-developed
-
Novavax
@Novavax
Our nanoparticle vaccine and adjuvant platform can be used to create investigational vaccines for existing and new pathogens, helping the world address global health threats. Learn more about our vaccines this #worldimmunizationweek: www.novavax.com/science-technology/recombinant-protein-ba…
-
Novavax
@Novavax
At Novavax, we're creating transformational vaccines that help address some of the world's most pressing infectious diseases. Learn more about our approach this #worldimmunizationweek:www.novavax.com/science-technology
-
Novavax
@Novavax
Results from the pediatric expansion of Novavax's Phase 3 PREVENT-19 trial were published in the @jamanetworkopen. The expansion evaluated the safety and effectiveness of our #covid19vaccine prototype in adolescents aged 12-17. Learn more: jamanetwork.com/journals/jamanetworkopen/fullarticle/2804216
-
Novavax
@Novavax
Even after your primary series vaccine, boosters can help protect you and your loved ones from dangerous infectious diseases. This #worldimmunizationweek, take some time to learn more about the importance and purpose of boosters: www.novavax.com/insights/why-do-we-need-vaccine-booster-i…
-
Novavax
@Novavax
Our Matrix-M adjuvant is a key element of our technology platform. This #worldimmunizationweek, explore the innovative science behind our vaccines: www.novavax.com/science-technology/matrix-m-adjuvant-tech…
-
Novavax
@Novavax
This #worldimmunizationweek, we encourage everyone to get up to date with their vaccinations in order to help protect themselves, their loved ones, and communities. Learn more about our protein-based #covid19vaccine: www.novavax.com
-
Novavax
@Novavax
Don't miss Chijoke Bennett, MD, MPH, Senior Director, Clinical Development, #covid with Matrix-M adjuvant in people living with HIV at #eccmid2023. Learn more: www.eccmid.org
-
Novavax
@Novavax
Seth Toback, MD, MMM, is delivering a presentation titled “Interim Analysis of an Observer-Blinded Randomized Phase 3 Study to Evaluate the Safety and Immunogenicity of a Single Booster of our #covid19vaccine in Adults Previously Vaccinated with a BBIBP-CorV Vaccine.”
-
Novavax
@Novavax
Additionally, Anthony Marchese, PhD will be presenting "Healthcare Provider Perceptions of Current and Future Uptake of COVID-19 Vaccines in Europe and North America." Don't miss out: www.eccmid.org
-
Novavax
@Novavax
Anthony Marchese, PhD, Medical Affairs Manager, will give a presentation titled "Reported Pregnancy Outcomes Across Novavax COVID-19 Vaccine Primary Series and Booster Dose Clinical Studies" at #eccmid2023. Read more: www.eccmid.org
-
Novavax
@Novavax
Novavax is excited to attend @ESCMID's #eccmid2023 in Copenhagen, Denmark! Will we see you there? www.eccmid.org
-
Novavax
@Novavax
The @UniofOxford-developed and @SerumInstIndia-manufactured malaria vaccine that contains Novavax's Matrix-M™ adjuvant– has been licensed for use in Ghana by the country's Food and Drug Authority. www.novavax.com/science-technology/malaria
-
Novavax
@Novavax
That's a wrap on #wvcusa! To learn more about Novavax and our protein-based #covid19vaccine, visit our website: www.novavax.com
-
Novavax
@Novavax
TODAY: Dr. Vivek Shinde, Novavax Vice President, will be speaking at a session titled Update on Novavax Influenza and COVID-Influenza Combination Vaccine at @vaccinenation's World Vaccine Congress. You won't want to miss this: www.terrapinn.com/conference/world-vaccine-congress-washi… #wvcusa
-
Novavax
@Novavax
TODAY: Lisa Dunkle, Vice President of Clinical Development Global Medical Lead, will be speaking at a session titled COVID-19 Vaccine: Latest Booster Data and Clinical Updates at @vaccinenation's World Vaccine Congress. Learn more: www.terrapinn.com/conference/world-vaccine-congress-washi… #wvcusa
-
Novavax
@Novavax
We're honored to be a finalist for "Best New Vaccine Technology/Platform" and "Best COVID Vaccine" at @vaccinenation's 2023 Vaccine Industry Excellence Awards! Thank you to our #novalutionary team behind our innovative science. Learn more: www.terrapinn.com/conference/world-vaccine-congress-washi…
-
Novavax
@Novavax
Novavax is excited to attend @vaccinenation's World Vaccine Congress. Will we
see you there? #wvcusa www.terrapinn.com/conference/world-vaccine-congress-washi… -
Novavax
@Novavax
Despite unprecedented healthcare collaboration during the #covid19 pandemic, many barriers and challenges with vaccine equity and uptake remain. Learn more from our Chief Corporate Affairs and Advocacy Officer, @SilT2, for @HLTHEVENT: www.hlth.com/digital-content/hlth-matters/blog/achieving-…
-
Novavax
@Novavax
At Novavax, we recognize that we have a responsibility to keep communities safe and combat #vaccine hesitancy. That's why we collaborate with private and public stakeholders to develop solutions for a healthier tomorrow. Learn more from @Forbes: www.forbes.com/sites/novavax/2023/03/02/building-vaccine-…
-
Novavax
@Novavax
We're proud to be named one of the ten most innovative companies in medicine for 2023 by @FastCompany! Read the full article: www.fastcompany.com/90848863/most-innovative-companies-me…
-
Novavax
@Novavax
We've announced a modification to our existing agreement with @HHSGov, in collaboration with the @DeptofDefense, to deliver up to 1.5 million doses of our #covid19vaccine. More: ir.novavax.com/2023-02-13-U-S-Government-and-Novavax-Exte…
Visit vaccines.gov for locations.
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. FDA, but has been authorized for emergency use as a primary series to prevent COVID-19 for individuals 12+ and as a first booster dose for individuals 18+. See conditions of use: us.novavaxcovidvaccine.com/non-hcp
-
Novavax
@Novavax
This International Day of Women and Girls in Science (#idwgs), we're shining a light on Novavax #womeninstem who are helping us create our vaccines. Learn more about the inspiring women on our Matrix-M™ Team in Uppsala, Sweden.👇
Post not available here, view on X
Novavax
@Novavax
What do you love about what you do? Anna-Karin Palm, Senior Scientist, tells us.
Novavax
@Novavax
What advice would you give to girls interested in pursuing a STEM career? Senior Program Manager, Sofia Magnusson, answers.
-
Novavax
@Novavax
Congratulations to our President and CEO, John C. Jacobs, for being named one of the Top 25 Healthcare Technology Leaders of Pennsylvania for 2023. Learn more about our new CEO from The Healthcare Technology Report: novav.ax/Top25HealthTech
-
Novavax
@Novavax
Novavax announces plan to deliver updated protein-based vaccine consistent with @US_FDA recommendations for 2023/2024 vaccination season at VRBPAC meeting. Learn more: novav.ax/3WKjpFo
-
Novavax
@Novavax
We welcome our new President & CEO John Jacobs to Novavax. John is a seasoned industry leader with more than 25 years of commercial, operations and business experience across therapeutic areas. Learn more: novav.ax/3XvTMcO
-
Novavax
@Novavax
NEW: Our partner, SK Bioscience, has received manufacturing and marketing approval from the Korean Ministry of Food and Drug Safety (@TheMFDS) for our #covid19vaccine as a booster for adults 18 and older. Learn more: novav.ax/3QMtrVg
-
Novavax
@Novavax
Novavax Names John C. Jacobs as New President & CEO
* Current President & CEO Stan Erck to retire
* Novavax is well-positioned to execute on its strategy, with global authorizations for its COVID-19 vaccine and continued clinical pipeline development
novav.ax/3XejXUT -
Novavax
@Novavax
Spain's Public Health Commission (CSP), Italy's @MinisteroSalute, and France's @HAS_sante have released updated recommendations expanding the use of our #covid19vaccine in their respective countries. Learn more: novav.ax/3GL2ez3
-
Novavax
@Novavax
El estudio pediátrico HUMMINGBIRD de Novavax está aceptando a niños de 6 a 11 años para un #ensayoclínico sobre una #vacuna en investigación a base de proteína sin ARNm contra el #covid19. Considere inscribirlos en estas fiestas: novav.ax/3Cd2NyI #covid19 #vacunacovid19
-
Novavax
@Novavax
Novavax' HUMMINGBIRD pediatric study is now enrolling children 6 to 11 years of age in a #clinicaltrial for a protein-based, non-mRNA investigational #vaccine to protect against #covid19. Consider enrolling this holiday season: novav.ax/3G96E0O #covid19 #covid19vaccine
-
Novavax
@Novavax
NEW: Novavax announced the initiation of our Phase 2 dose-confirming trial in Australia for our COVID-19-Influenza Combination (CIC) vaccine candidate. The trial will evaluate the safety and effectiveness of the #cicvaccine in adults aged 50-80. Learn more:novav.ax/3vsNVsm
-
Novavax
@Novavax
Por si no lo sabía: El estudio pediátrico HUMMINGBIRD está aceptando a niños de 6 a 11 años para que participen en un #ensayoclínico. Les pedimos a los padres y las madres que inscriban a sus hijos en estas fiestas: novav.ax/3vpKx1a #covid19 #vacunacovid19
-
Novavax
@Novavax
ICYMI: The HUMMINGBIRD pediatric study is now enrolling children 6 to 11 years of age to participate in a #clinicaltrial. Parents, take time to enroll your children this holiday season: novav.ax/3jww5C6 #covid19 #covid19vaccine
-
Novavax
@Novavax
Happy holidays to our vaccine heroes! Because sometimes getting that booster shot makes it possible to safely reunite with loved ones, and that’s pretty heroic. Thank you for supporting global public health and making the holiday season
merrier! -
Novavax
@Novavax
NEW: The Standing Committee on Vaccination at the Robert Koch Institute (STIKO) in Germany has expanded its recommendation for our #covid19vaccine as a booster. Learn more: novav.ax/3uXGXLI
-
Novavax
@Novavax
TODAY: We announced that Switzerland's @BAG_OFSP_UFSP and France's @HAS_sante recommend our #covid19vaccine, adjuvanted as a booster. Read more: novav.ax/3PiPmCC
-
Novavax
@Novavax
TODAY: We announced that @GovCanHealth has granted approval for our #covid19vaccine as a primary series of two doses in adolescents aged 12 through 17. Learn more: novav.ax/3VwdIeB
-
Novavax
@Novavax
NEW: The @WHO has issued an updated Emergency Use Listing (EUL) for our #covid19vaccine as a primary series of two doses in adolescents aged 12 through 17 and as a booster in adults aged 18 and older. Learn more: novav.ax/3GUwEPC
-
Novavax
@Novavax
Novavax' HUMMINGBIRD pediatric study is now enrolling children 6 months to 11 years of age in a #clinicaltrial to study a protein-based, non-mRNA #vaccine to protect against #covid19. Consider enrolling in this Thanksgiving break: novav.ax/3Ezo2LC #covid19 #covid19vaccine
-
Novavax
@Novavax
Attention parents: The HUMMINGBIRD pediatric study is now enrolling children 6 to 11 years of age to participate in a #clinicaltrial for our protein-based, non-mRNA #vaccine. Take time to enroll them this Thanksgiving holiday: novav.ax/3GRIFW3 #covid19 #covid19vaccine
-
Novavax
@Novavax
This Thanksgiving break, consider enrolling your children in Novavax' HUMMINGBIRD pediatric #clinicaltrial for our protein-based, non-mRNA #vaccine for children 6 to 11 years of age. Learn more: novav.ax/3VqoiDz #covid19 #covid19vaccine
-
Novavax
@Novavax
TODAY: We announced that @GovCanHealth has granted expanded authorization for our #covid19 vaccine as a booster in adults 18 and older. Learn more: novav.ax/3UVjgiE
-
Novavax
@Novavax
Novavax is a proud grant provider of the @BCAgainstCOVID "COVID and the Holidays" town hall tonight. With the holidays approaching, more than half of Americans haven’t yet received a #covid19vaccine booster. At 7pm ET, learn more about getting boosted: novav.ax/3hPfQip
-
Novavax
@Novavax
On #veteransday, and every day, we're thankful for the #veterans on our Novavax team.
-
Novavax
@Novavax
If you're attending the @RecruitMilitary Greater Washington DC Area Veteran's Job Fair on November 10th, make sure to stop by our Novavax booth and discover what it means to #benovalutionary! Learn more: novav.ax/3fOF2VV
-
Novavax
@Novavax
NEW: The @MHRAgovuk has expanded the conditional marketing authorization (CMA) for our #covid19vaccine as a #booster in adults aged 18 and older. Learn more: novav.ax/3E0yxHI
-
Novavax
@Novavax
TODAY: Topline results from our Phase 3 Boosting Trial of the #covid19 Variant Vaccines show that the BA.1 vaccine candidate met its primary strain-change endpoint. Learn more: novav.ax/3Ulzp0h
-
Novavax
@Novavax
NEW: Rick Rodgers, MBA has been appointment to our Board of Directors as an independent director. Mr. Rodgers brings extensive experience in #biopharmaceutical management to his new role. Learn more: ir.novavax.com/2022-11-01-Novavax-Appoints-Rick-Rodgers-t…
-
Novavax
@Novavax
Thank you to everyone who visited our booth and engaged with us at #idweek2022! To learn more about Novavax, visit our website: novav.ax/3TNShUX
-
Novavax
@Novavax
Calling all attendees of @IDWeek2022: visit us at the Novavax Sponsored Learning Lounge to learn more about "Using Behavioral Science to Help Understand Vaccine Hesitancy." You won't want to miss out! #idweek2022
-
Novavax
@Novavax
TODAY: Don't miss our Vice President, Vaccine Clinical Development, Dr. Vivek Shinde's presentation, "Safety and Immunogenicity of COVID Influenza Combination Vaccine," from 12:15-1:30pm EST at @IDWeek2022. Will you be there? #idweek2022
-
Novavax
@Novavax
NEW: Novavax showcased data from expanding vaccine portfolio at IDWeek 2022: ir.novavax.com/2022-10-20-Novavax-Showcases-Data-from-Exp… #idweek2022
-
Novavax
@Novavax
TUNE IN: @ganezg will be giving an oral presentation on "Safety and Immunogenicity of a Booster Dose of Novavax COVID-19 Vaccine, Adjuvanted (NVX-CoV2373) in Adults from the PREVENT-19 Trial in the United States" today from 1:57-2:09pm EST. Don't miss this! #idweek2022
-
Novavax
@Novavax
Novavax is a proud sponsor of @IDWeek2022 taking place in Washington, D.C. from October 19 -23! If you are planning to attend, make sure to stop by the Novavax booth to learn more about what it means to #benovalutionary. #idweek2022
-
Novavax
@Novavax
Today, we announced that our COVID-19 vaccine is now available as a first booster dose in the U.S. for adults. (🧵1/2) For locations visit www.vaccines.gov.
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. FDA, but has been authorized for emergency use as a primary series to prevent COVID-19 for individuals 12+ and as a first booster dose for individuals 18+. See conditions of use: www.fda.gov/emergency-preparedness-and-response/coronavir…
-
Novavax
@Novavax
Thank you to everyone who joined us at #wvceu! To learn more about Novavax, visit our website: novav.ax/3CvEhIy
-
Novavax
@Novavax
Thank you to everyone who attended the 2022 Vaccines Summit! To learn more about Novavax, visit our website: novav.ax/3CAxXiS
-
Novavax
@Novavax
TODAY: Make sure to attend Dr. Vivek Shinde's presentation "Update on Novavax Investigational Influenza vaccine and COVID-19-INFLUENZA Combination Vaccine development" at @vaccinenation World Vaccine Congress Europe! You won't want to miss it. #wvceu
-
Novavax
@Novavax
TODAY: Our very own Lisa Dunkle, Vice President of Research, will give a presentation on "COVID-19 Vaccine Registration Clinical Trials: Building the Plane While Flying" at the 2022 Vaccines Summit. You won't want to miss it!
-
Novavax
@Novavax
Novavax is proud to sponsor Vaccines Summit 2022 in Washington, D.C on October 11-13th! Will we see you there?
-
Novavax
@Novavax
Novavax is a proud sponsor of the @vaccinenation Vaccine Congress Europe! We'll be in Barcelona to partake in discussions alongside leaders in pharma and biotech. Make sure to visit our booth to learn more about Novavax. #wvceu
-
Novavax
@Novavax
NEW: Switzerland's Federal Office of Public Health (@BAG_OFSP_UFSP) has recommended our #covid19vaccine as a booster in adults aged 18 and older regardless of previous vaccine history. Learn more: novav.ax/3V9xqx3
-
Novavax
@Novavax
TODAY: Novavax partner, SK bioscience, has submitted a Post Approval Change Application to the Korean Ministry of Food and Drug Safety (@TheMFDS) for our #covid19vaccine as a booster for adults aged 18 and older. Learn more: novav.ax/3elUvMm
-
Novavax
@Novavax
Thank you to everyone who attended "The Shift to Endemic: Living Alongside COVID-19" featuring our very own Chief Commercial Officer, @jtrizzino, at @MDTechCouncil Bio Innovation Conference! #mdlsbioinnovation
-
Novavax
@Novavax
Novavax today announced that an initial one million doses of our #covid19vaccine are now available for use in the United Kingdom. Those eligible for the vaccine will be identified by their healthcare providers. Learn more: novav.ax/3DYoR1Y
-
Novavax
@Novavax
The Taiwan Food and Drug Administration has granted emergency use authorization (EUA) for our #covid19vaccine in adolescents aged 12-17. Learn more: novav.ax/3S9hys1
-
Novavax
@Novavax
NEW: Novavax announced that the @IsraelMOH has granted an import permit that allows physicians to access our #covid19vaccine as a primary series in individuals aged 12 and older and as a booster in adults aged 18 and older. Learn more: novav.ax/3DvkPxD
-
Novavax
@Novavax
We're excited to share that our very own Dr. Henrietta Ukwu has been named by @PharmaVoice as one of the 100 Most Inspiring People in the life sciences. Thank you for all that you do to help us #benovalutionary! www.pharmavoice.com/news/henrietta-ukwu-pv100-legacy-lead… #pharmavoice100
-
Novavax
@Novavax
NEW: Novavax and Serum Institute of India announced that South Africa's @SAHPRA1 has registered our #covid19vaccine as a two-doses primary series in adults aged 18 and older. Learn more: ir.novavax.com/press-releases/2022-09-13-Novavax-and-Seru…
-
Novavax
@Novavax
NEW: Novavax announced that our @EU_Commission has approved our #covid19vaccine for expanded conditional marketing authorization in the European Union as a booster for adults aged 18 and older regardless of previous vaccine history. Learn more: ir.novavax.com/press-releases/2022-09-12-Novavax-Nuvaxovi…
-
Novavax
@Novavax
#vaccine research can help our children SOAR beyond #covid19. Novavax' HUMMINGBIRD pediatric COVID-19 study, for children 6 months to 11 years of age, is now enrolling. Learn more: novavaxpediatricvaccine.com?sf169864820=1
-
Novavax
@Novavax
Now enrolling: a pediatric #covid19 #vaccine study for children 6 months to 11 years of age. Learn more about the HUMMINGBIRD #clinicaltrial: novavaxpediatricvaccine.com?sf169864806=1
-
Novavax
@Novavax
NEW: @Swissmedic_ authorizes Novavax COVID-19 Vaccine for adolescents aged 12 through 17 and as a booster in adults aged 18 and older. Learn more: ir.novavax.com/press-releases/2022-09-02-Swissmedic-Autho…
-
Novavax
@Novavax
#vaccine research can help our children SOAR beyond #covid19. Novavax' HUMMINGBIRD pediatric COVID-19 study, for children 6 months to 11 years of age, is now enrolling. Learn more: novavaxpediatricvaccine.com?sf169864795=1
-
Novavax
@Novavax
World Health Organization Approves SK bioscience as a Supplier of Novavax Nuvaxovid™ COVID-19 Vaccine ir.novavax.com/press-releases/World-Health-Organization-A…
-
Novavax
@Novavax
Novavax announced that our #covid19vaccine has been recommended for expanded conditional marketing authorization in the European Union by @EMA_News's Committee for Medicinal Products for Human Use as a booster for adults aged 18 and older. Learn more: ir.novavax.com/press-releases/2022-09-01-Novavax-Nuvaxovi…
-
Novavax
@Novavax
NEW: Novavax announced that the @MHRAgovuk has granted expanded conditional marketing authorization (CMA) for our #covid19vaccine for active immunization in adolescents aged 12-17. Learn more: ir.novavax.com/press-releases/2022-08-26-Novavax-Nuvaxovi…
-
Novavax
@Novavax
U.S. Centers for Disease Control and Prevention Expands Recommendation for Novavax COVID-19 Vaccine, Adjuvanted to Adolescents Aged 12 Through 17 (🧵1 of 2) ir.novavax.com/U-S-Centers-for-Disease-Control-and-Preven…
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 12+. (🧵2 of 2) See conditions of use: us.novavaxcovidvaccine.com/non-hcp
-
Novavax
@Novavax
Kelsey Hoontis, Associate Director of Regulatory Affairs, CMC, joined Novavax to make a difference. Join our team and #benovalutionary: www.novavax.com/people-culture?sf169420585=1
This media couldn't be displayed. See it on the original post. -
Novavax
@Novavax
NEW: The Novavax #covid19vaccine has received emergency use authorization (EUA) from the @US_FDA to provide a two-dose primary series in adolescents aged 12 -17, in addition to the existing 18+ EUA. (🧵1 of 2) Learn more: ir.novavax.com/2022-08-19-U-S-FDA-Grants-Emergency-Use-Au…
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 12+. (🧵2 of 2) See conditions of use: www.fda.gov/emergency-preparedness-and-response/coronavir…
-
Novavax
@Novavax
Novavax’ #covid19vaccine has been granted expanded provisional approval in New Zealand for adolescents aged 12 through 17. ir.novavax.com/press-releases/2022-08-18-Novavax-Nuvaxovi…
-
Novavax
@Novavax
Novavax announced that a U.S. government delegation visited @SerumInstIndia (SII), celebrating the importance and impact of 75 years of U.S.-India bilateral partnership. The event also highlighted the partnership between Novavax and SII. Learn more: ir.novavax.com/press-releases/Novavax-COVID-19-Vaccine-Re…
-
Novavax
@Novavax
NEW: Novavax announced that New Zealand's Medsafe has granted expanded provisional approval for our #covid19vaccine as a booster dose in adults aged 18 and older. Learn more: ir.novavax.com/press-releases/2022-08-17-Novavax-Nuvaxovi…
-
Novavax
@Novavax
NEW: Novavax has submitted a request to Taiwan’s Food and Drug Administration for expanded Emergency Use Authorization (EUA) of our #covid19vaccine in adolescents aged 12-17. Learn more: ir.novavax.com/press-releases/Novavax-Files-in-Taiwan-for…
-
Novavax
@Novavax
NEW: Novavax submitted our application to the @US_FDA for Emergency Use Authorization for Novavax #covid19vaccine as a booster, if authorized, Novavax’ vaccine would be the first protein-based COVID-19 booster for adults. Learn more: ir.novavax.com/2022-08-15-Novavax-Submits-Application-to-…
(1/2)
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 18+. See conditions of use: us.novavaxcovidvaccine.com/non-hcp (2/2)
-
Novavax
@Novavax
Novavax and our partner SK bioscience are pleased to announce our protein-based #covid19vaccine has been approved for adolescents ages 12-17 in South Korea. Learn more here: ir.novavax.com/press-releases/2022-08-12-Novavax-Nuvaxovi…
-
Novavax reposted
CDC
@CDCgov
Novavax’s #covid19 vaccine is another important tool in the pandemic. It is a protein subunit vaccine, a type used safely in the U.S. for over 30 years. If you’re not vaccinated against COVID-19, now is the time.
Find a vaccine near you: www.vaccines.gov. -
Novavax
@Novavax
This National Immunization Month, talk to your healthcare provider about protecting yourself and your loved ones against serious diseases by getting caught up on routine vaccination. Learn more from @CDCgov: www.cdc.gov/vaccines/events/niam/parents/educational-reso…
-
Novavax
@Novavax
TODAY: Novavax Announces Initiation of Phase 2b/3 Hummingbird™ Global Clinical Trial for the Novavax #covid19vaccine in Children Aged Six Months Through 11 Years. Learn more: ir.novavax.com/press-releases/2022-08-04-Novavax-Announce…
-
Novavax
@Novavax
Novavax Statement on U.S. Vaccinations with the Novavax #covid19vaccine Underway: ir.novavax.com/Novavax-Statement-on-U-S-Vaccinations-with…
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 18+. See conditions of use: us.novavaxcovidvaccine.com/non-hcp
-
Novavax
@Novavax
Novavax announced the submission of a request to the @WHO to expand the Emergency Use Listing (EUL) of our #covid19vaccine for adolescents aged 12-17. Learn more: ir.novavax.com/press-releases/Novavax-Requests-Expanded-E…
-
Novavax
@Novavax
Our President and CEO, Stanley Erck, has been appointed by the @CommerceGov to the U.S.-India CEO Forum, a high-level group of U.S. and Indian CEOs that engage directly with both governments on policies that focus on commercial priorities: ir.novavax.com/press-releases/Novavax-CEO-Appointed-to-U-…
-
Novavax
@Novavax
The Novavax COVID-19 Vaccine, Adjuvanted is now on vaccines.gov. Visit the site to enter your zip code and find the location nearest you. Locations will continually update, so check back if there is not a location near you.
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 18+. See conditions of use: us.novavaxcovidvaccine.com/non-hcp
-
Novavax
@Novavax
NEW: The Novavax #covid19vaccine received expanded manufacturing and marketing approval from Japan's @MHLWitter in adolescents aged 12-17. Learn more: ir.novavax.com/press-releases/2022-07-26-Novavax-Announce…
-
Novavax
@Novavax
TODAY: Novavax announced that Australia's @TGAgovau has granted expanded approval for provisional registration of the Novavax #covid19vaccine for adolescents aged 12-17. Learn more: ir.novavax.com/press-releases/2022-07-26-Novavax-Nuvaxovi…
-
Novavax reposted
Tedros Adhanom Ghebreyesus
@DrTedros
The #covid19 Emergency Committee met & concluded that the outbreak remains a Public Health Emergency of International Concern. New waves of the virus show that the pandemic is not over. We must push back with safe & effective tools to prevent infections, hospitalizations & deaths
World Health Organization (WHO)
@WHO
Statement on the 12th meeting of the International Health Regulations (2005) Emergency Committee on #covid19. The pandemic continues to be a Public Health Emergency of International Concern.
More:
📌 www.who.int/news/item/12-07-2022-statement-on-the-twelfth… -
Novavax
@Novavax
Novavax Statement on U.S. Availability of the Novavax COVID-19 Vaccine, Adjuvanted: ir.novavax.com/Novavax-Statement-on-U-S-Availability-of-t…
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 18+. See conditions of use: www.fda.gov/emergency-preparedness-and-response/coronavir…
-
Novavax
@Novavax
U.S. Centers for Disease Control and Prevention Endorses Advisory Committee on Immunization Practices’ Recommendation for Novavax COVID-19 Vaccine, Adjuvanted ir.novavax.com/U-S-Centers-for-Disease-Control-and-Preven…
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 18+. See conditions of use: www.fda.gov/emergency-preparedness-and-response/coronavir…
-
Novavax reposted
CDC Director
@CDCDirector
Today, I endorsed ACIP’s recommendation that Novavax’s #covid19 vaccine be used as another primary series option for adults 18 & older.
For those waiting for a COVID-19 vaccine built on a different technology, now is the time to get vaccinated.
More: www.cdc.gov/media/releases/2022/s0719-covid-novavax-vacci… -
Novavax
@Novavax
U.S. CDC Advisory Committee Unanimously Recommends Novavax COVID-19 Vaccine, Adjuvanted as a Primary Series for Individuals Aged 18 and Older: ir.novavax.com/2022-07-19-U-S-CDC-Advisory-Committee-Unan…
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 18+. See conditions of use: www.fda.gov/emergency-preparedness-and-response/coronavir…
-
Novavax
@Novavax
Novavax Announces Expanded Agreement with SK bioscience to Manufacture #covid19vaccine Containing #omicron Variant and Manufacture the Novavax COVID-19 Vaccine in Prefilled Syringes: ir.novavax.com/press-releases/2022-07-19-Novavax-Announce…
-
Novavax
@Novavax
Novavax COVID-19 Vaccine, Adjuvanted to be Reviewed at U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices Meeting on July 19, 2022: ir.novavax.com/Novavax-COVID-19-Vaccine-to-be-Reviewed-at…
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 18+.
Novavax
@Novavax
Please see the Fact Sheet for Recipients and Caregivers for more information: novavax.widen.net/s/x5p5tqsdgw/us-eua-fact-sheet-recipients
-
Novavax
@Novavax
In case you missed yesterday’s big announcement. our protein-based #covid19vaccine is authorized for emergency use by the FDA for primary series vaccination in individuals 18+. [🧵1 of 2] Read more: ir.novavax.com/2022-07-13-U-S-FDA-Grants-Emergency-Use-Au…
Novavax
@Novavax
The Novavax COVID-19 vaccine is authorized for emergency use as a primary series to prevent COVID-19 in individuals 18+. [🧵2 of 2]
-
Novavax
@Novavax
We’ve got big news. Our protein-based #covid19vaccine is now authorized for 18+ primary series under emergency use in the United States. [🧵1 of 2] Read more: ir.novavax.com/2022-07-13-U-S-FDA-Grants-Emergency-Use-Au…
Novavax
@Novavax
The Novavax COVID-19 vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized for emergency use as a primary series to prevent COVID-19 in individuals 18+. [🧵2 of 2]
-
Novavax
@Novavax
U.S. Government Secures 3.2 Million Doses of Novavax #covid19vaccine: ir.novavax.com/press-releases/2022-07-11-U-S-Government-S…
-
Novavax
@Novavax
Novavax announced the filing of a request to @Swissmedic_ to expand the conditional marketing authorization (CMA) of our #covid19vaccine in Switzerland in adolescents aged 12-17 and as a booster dose for individuals aged 18 and over. Learn more: ir.novavax.com/press-releases/Novavax-Files-in-Switzerlan…
-
Novavax reposted
Tedros Adhanom Ghebreyesus
@DrTedros
We have made tremendous progress in reducing #covid19 mortality and transmission. But cases are still on the rise in 110 countries. Our job is not over. We must ensure that all countries are equipped to fight current and future waves of this virus. #actogether
-
Novavax
@Novavax
European Medicines Agency Approves SK bioscience as a Supplier of Novavax #covid19vaccine: ir.novavax.com/press-releases/European-Medicines-Agency-A…
-
Novavax
@Novavax
They’re here! The first doses of the Novavax #covid19vaccine have arrived in the United States. We look forward to sharing more updates in the upcoming weeks. It’s important to note that the Novavax COVID-19 vaccine has not yet been authorized or approved by the FDA.
-
Novavax
@Novavax
New: The @EU_Commission has approved the expanded conditional marketing authorization for the Novavax #covid19vaccine in the European Union for adolescents aged 12 through 17. Learn more: ir.novavax.com/press-releases/2022-07-05-Novavax-Nuvaxovi…
-
Novavax
@Novavax
Novavax Statement on Prototype Vaccine’s Broad Immune Responses and Accelerated Focus on Omicron BA.4/5 as Recommended by the FDA: ir.novavax.com/press-releases/Novavax-Statement-on-Protot…
-
Novavax
@Novavax
TODAY: Novavax participated in the FDA VRBPAC meeting which resulted in a 19-2 vote to recommend inclusion of a SARS-CoV-2 Omicron component for #covid19booster vaccines in the U.S. beginning this fall. ir.novavax.com/press-releases/2022-06-28-Novavax-COVID-19…
-
Novavax
@Novavax
TODAY: Our very own @jtrizzino will be participating in the Panel Discussion The Last Mile: Coming Together to Make Vaccines Make a Difference at #aspenideashealth. Will you be there?
-
Novavax
@Novavax
NEW: The Taiwan Food and Drug Administration has granted emergency use authorization for Novavax' #covid19vaccine in individuals aged 18 and over. Learn more: ir.novavax.com/press-releases/2022-06-23-Novavax-Nuvaxovi…
-
Novavax
@Novavax
Novavax announced that our #covid19vaccine has been recommended for expanded conditional marketing authorization in the European Union by @EMA_News Committee for Medicinal Products for Human Use for adolescents aged 12-17. Learn more: ir.novavax.com/press-releases/2022-06-23-Novavax-COVID-19…
-
Novavax
@Novavax
Are you attending #aspenideashealth? Be sure to visit the Novavax Networking Space in the Marble Garden Tent. We invite visitors to participate in our giving activity by showing support to organizations already making a difference in protecting public health.
-
Novavax
@Novavax
NEW: Novavax filed a supplement to a New Drug Submission with @GovCanHealth to expand the authorization of our #covid19vaccine in adolescents aged 12-17. Learn more: ir.novavax.com/press-releases/Novavax-Files-Supplement-to…
-
Novavax
@Novavax
If you're attending #aspenideashealth don't miss out on @jtrizzino in the Panel Discussion The Last Mile: Coming Together to Make Vaccines Make a Difference. See you there!
-
Novavax
@Novavax
We're excited to join @AspenIdeas Health this year and the important healthcare conversations vital to protecting public health.
Novavax will have a networking space in the Marble Garden Tent, will we see you there? #aspenideashealth -
Novavax
@Novavax
Novavax will be giving six different presentations showcasing our vaccine data at Australia's Communicable Diseases & Immunisation Conference, #cdic2022. Learn more: ir.novavax.com/press-releases/Novavax-to-Showcase-Innovat…
-
Novavax
@Novavax
Today, @jtrizzino stopped by #gooddaybio at @BIOconvention. See what he had to say:
-
Novavax
@Novavax
Learn more about yesterday’s @BIOConvention “Stopping the Next Pandemic Before it Starts: What We’ve Learned” panel with @jtrizzino and @AnjKhem: bio.news/bio-convention/experts-on-lessons-from-covid-imp…
-
Novavax
@Novavax
TODAY: If you're attending #bio2022, make sure to watch the Super Session featuring our very own Chief Commercial Officer, @jtrizzino, for a discussion on lessons learned from the #covid19 pandemic and rapid developing of innovative vaccines. Details ⬇️
-
Novavax
@Novavax
NEW: Australia's @TGAgovau has granted provisional registration to the Novavax #covid19vaccine as a booster in individuals aged 18 and over. Learn more: ir.novavax.com/press-releases/2022-06-13-Novavax-COVID-19…
-
Novavax
@Novavax
New: FDA Advisory Committee Recommends Emergency Use Authorization of Novavax #covid19vaccine for People Aged 18 Years and Older ir.novavax.com/press-releases/2022-06-07-FDA-Advisory-Com…
-
Novavax
@Novavax
NEW: Novavax announced the submission of a request to the @MHRAgovuk in Great Britain to expand the conditional marketing authorization of our #covid19vaccine as a #booster for individuals aged 18 and over. Learn more: ir.novavax.com/press-releases/Novavax-Files-in-the-United…
-
Novavax
@Novavax
America, have you been waiting for more #covid19vaccine choices?
-
Novavax
@Novavax
NEW: Novavax is initiating a Phase 3 Trial of our #omicron strain #covid19vaccine as a #booster. Learn more: ir.novavax.com/press-releases/Novavax-Initiates-Phase-3-T…
-
Novavax
@Novavax
FDA Confirms Vaccines and Related Biological Products Advisory Committee (VRBPAC) Review of Novavax’ COVID-19 Vaccine on June 7, 2022 ir.novavax.com/press-releases/FDA-Confirms-Vaccines-and-R…
-
Novavax
@Novavax
Novavax will consider accepting unsolicited requests for support of independent research that addresses unmet scientific or medical needs through our Investigator-Initiated Studies (IIS) program. Submit a study concept or proposal: medical.novavax.com/investigator-initiated-studies?sf1652…
-
Novavax
@Novavax
NEW: Novavax announces participation in @UniofOxford's Com-COV3 #booster trial of #covid19vaccines in adolescents aged 12-15. Learn more: ir.novavax.com/Novavax-Announces-Participation-in-Oxford-…
-
Novavax
@Novavax
NEW: Novavax announced the submission of a request to the @EU_Commission for expanded conditional marketing authorization of our #covid19vaccine in the European Union as a #booster in adults aged 18 and over. Learn more: ir.novavax.com/press-releases/Novavax-Files-in-the-Europe…
-
Novavax
@Novavax
NEW: Novavax announced the submission of a request for emergency use authorization to Taiwan’s Food and Drug Administration for its #covid19 vaccine. Learn more: ir.novavax.com/press-releases/Novavax-Files-for-Emergency…
-
Novavax
@Novavax
Novavax’ #covid19vaccine Arrives in Singapore: ir.novavax.com/press-releases/Novavax-COVID-19-Vaccine-Nu…
-
Novavax
@Novavax
Novavax Submits Variations to Expand Australian and New Zealand Provisional Approval of It's #covid19vaccine to Adolescents aged 12 Through 17 Years: ir.novavax.com/press-releases/Novavax-Submits-Variations-…
-
Novavax
@Novavax
Novavax has submitted a request to expand the authorization of our COVID-19 Vaccine (recombinant, adjuvanted) for adolescents aged 12 to 17 years to the @MHRAgovuk in the #unitedkingdom (UK). Learn more: ir.novavax.com/press-releases/Novavax-Requests-Expanded-A…
-
Novavax
@Novavax
FDA Announces Vaccines and Related Biological Products Advisory Committee (VRBPAC) Review of Novavax’ COVID-19 Vaccine ir.novavax.com/press-releases/2022-04-29-FDA-Announces-Va…
-
Novavax
@Novavax
It was a pleasure meeting with our global vaccine industry colleagues at @vaccinenation's #wvcdc. For those we didn't connect with, learn more on our discovery, development, and delivery of innovative vaccines to patients around the world here: www.novavax.com/newsroom?sf163587434=1
-
Novavax
@Novavax
We are proud to announce the initiation of our #covid19 Vaccine Booster Study in adolescents in Phase 3 of the PREVENT-19 Trial. More: ir.novavax.com/press-releases/2022-04-22-Novavax-Announce…
-
Novavax
@Novavax
Today we announced the initial results from the Phase 1/2 clinical trial of the investigational Novavax COVID-19-Influenza Combination Vaccine. Read more: ir.novavax.com/press-releases/2022-04-20-Initial-Results-…
-
Novavax
@Novavax
Tomorrow at @vaccinenation hear from Dr. Gregory M. Glenn, Novavax's President of Research and Development, as well as other industry experts, on the topic of how long will our immunity against COVID will last. #wvcdc
-
Novavax
@Novavax
Novavax today announced that its partner, Takeda, received approval from the Japan Ministry of Health, Labour and Welfare for its novel recombinant protein-based COVID-19 vaccine, for primary and booster immunization in individuals aged 18 and older: ir.novavax.com/press-releases/2022-04-19-Novavax-Announce…
-
Novavax
@Novavax
We're honored to be here at @vaccinenation 2022 #wvcdc to collaborate with other esteemed colleagues and contribute to the future of vaccines!
-
Novavax
@Novavax
Novavax will provide a first look at data from our investigational #covid19 influenza combo vaccine and seasonal flu vaccine trials at @vaccinenation. In addition, the latest data on our #covid19vaccine candidate will be presented at both WVC and @ESCMID: ir.novavax.com/press-releases/2022-04-18-Novavax-Grows-Pr…
-
Novavax
@Novavax
It’s here! Today, we are excited to share that the new Novavax corporate website has launched. It’s contemporary and intuitive—telling the story of our science, our people, and our desire to build a brighter future for all.
-
Novavax
@Novavax
We are pleased to announce that the Swiss Agency for Therapeutic Products @Swissmedic_ has granted Conditional Marketing Authorization for our protein-based #covid19vaccine in Switzerland. Read more: ir.novavax.com/press-releases/2022-04-13-Swissmedic-Grant…
-
Novavax
@Novavax
Novavax and Serum Institute of India Receive Emergency Use Authorization for Novavax’ COVID-19 Vaccine in Thailand: ir.novavax.com/press-releases/2022-04-08-Novavax-and-Seru…
-
Novavax
@Novavax
Novavax Statement on Arrival of its COVID-19 Vaccine in Canada: ir.novavax.com/press-releases/Novavax-Statement-on-Arriva…
-
Novavax
@Novavax
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17): ir.novavax.com/press-releases/2022-03-31-Novavax-Submits-…
-
Novavax
@Novavax
Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine: ir.novavax.com/press-releases/2022-03-25-Novavax-Announce…
-
Novavax
@Novavax
Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India: ir.novavax.com/press-releases/2022-03-22-Novavax-and-Seru…
-
Novavax
@Novavax
ICYMI: We recently announced results that expand our knowledge of NVX-CoV2373 and its ability to help protect from COVID19 over a longer period of time. Let's talk about what it means. Thread:
Post not available here, view on X
Novavax
@Novavax
These encouraging findings suggest that NVX-CoV2373 may have a positive impact on disease transmission and protection over a longer period of time.
Novavax
@Novavax
Thank you. Novavax is grateful to the thousands of people around the world who are volunteering for our vaccine studies. We thank the U.S. Government, @CEPIvaccines & other govts for their significant support of our work.
-
Novavax
@Novavax
Novavax announced the launch of its global unbranded 'We Do Vaccines’ & 'Know Our Vax’ programs, educational efforts aimed to help protect the health of people everywhere in the fight against COVID-19 & other deadly infectious diseases, such as influenza: ir.novavax.com/2022-03-10-Novavax-Announces-Launch-of-Glo…
Novavax
@Novavax
wedovaccines.com is the new consumer website, providing educational information about the common types of vaccines and how they work, how vaccines are made and tested, and how Novavax’ approach to technology makes it's vaccines different.
Novavax
@Novavax
knowourvax.com is the new health care professional website, providing educational information about Novavax, its global approach, and tried and true technology.
-
Post not available here, view on XPost not available here, view on X
Novavax
@Novavax
Summary: Reassuring top-line safety profile. Clinical efficacy maintained over 6 months of surveillance. 100% efficacy against severe disease. 82.5% protection against all infection.
Novavax
@Novavax
These encouraging findings suggest that NVX-CoV2373 may have a positive impact on disease transmission and protection over a longer period of time.
Novavax
@Novavax
Thank you. Novavax is grateful to the thousands of people around the world who are volunteering for our vaccine studies. We thank the U.S. Government, @CEPIvaccines & other govts for their significant support of our work.
-
Novavax
@Novavax
Novavax Statement on Availability of its COVID-19 Vaccine in New Zealand: ir.novavax.com/Novavax-Statement-on-Availability-of-its-C…
-
Novavax
@Novavax
Novavax Announces Extended Durability of Protection Against Infection and Disease in United Kingdom COVID-19 Vaccine Phase 3 Clinical Trial: ir.novavax.com/press-releases/2022-02-28-Novavax-Announce…
-
Novavax
@Novavax
Stop One in Europe: Complete. Today we delivered our first lot of #covid19 vaccines to France.
Post not available here, view on X
Novavax
@Novavax
Novavax
@Novavax
Thank you to the thousands of clinical trial participants, our partners and Novavax employees worldwide who have contributed to this milestone.
-
Novavax
@Novavax
Join our Novavax summer intern program to make an impact on global public health. We’re hiring across more than thirty different departments – from business operations to cyber security to marketing and medical affairs. Visit novavax.com/careers to learn more.
-
Novavax
@Novavax
We’re thrilled the first lots of our #covid19 vaccine have begun shipping to the European Union member states today. Read more: ir.novavax.com/press-releases/2022-02-23-Novavax-Announce…
-
Novavax
@Novavax
Novavax’ COVID-19 vaccine has begun being administered in South Korea. Read more: www.news1.kr/articles/?4584200&sf160540205=1
-
Novavax
@Novavax
We are pleased to announce that Health Canada (@GovCanHealth) has granted authorization of the Novavax COVID-19 vaccine – the first protein-based #covid19vaccine in Canada.
Read more: ir.novavax.com/press-releases/2022-02-17-Health-Canada-Au… -
Novavax
@Novavax
We are pleased to announce that the Health Sciences Authority (@HSAsg) has issued interim authorization of the Novavax #covid19vaccine - the first protein-based #covid19vaccine in Singapore. ir.novavax.com/press-releases/2022-02-14-Singapore-Health…
-
Novavax
@Novavax
We are pleased to announce that Novavax has filed for Conditional Marketing Authorization with SwissMedic for the Novavax protein-based #covid19vaccine candidate in Switzerland. ir.novavax.com/press-releases/2022-02-14-Novavax-Files-fo…
-
Novavax
@Novavax
Novavax Statement on First Administration of its COVID-19 Vaccine in Australia: ir.novavax.com/Novavax-Statement-on-First-Administration-…
-
Novavax
@Novavax
Today we're thrilled to announce results of our PREVENT-19 Phase 3 pediatric expansion to adolescents (ages 12 through 17). Let's talk about the data and what they mean. Thread:
Post not available here, view on X
Novavax
@Novavax
Vaccine efficacy was very similar between older and younger children.
Novavax
@Novavax
We saw 82% efficacy against Delta VOC, generally matching the overall efficacy observed in the adult study, where we saw efficacy >90%, including against variants, and complete protection against moderate & severe disease.
Post not available here, view on X
Novavax
@Novavax
Novavax looks forward to supplementing our global regulatory findings with results from this pediatric expansion. Additional pediatric studies are expected to start in Q2.
Novavax
@Novavax
Thank you. Novavax is grateful to the thousands of people around the world who are volunteering for our vaccine studies. We thank the U.S. Government, @CEPIvaccines & other governments for their significant support of our work.
-
Novavax
@Novavax
Novavax Announces Positive Results of COVID-19 Vaccine in Pediatric Population of PREVENT-19 Phase 3 Clinical Trial: ir.novavax.com/press-releases/2022-02-10-Novavax-Announce…
-
Novavax
@Novavax
“Novavax is proud to join COVIDRIVE and partner across the healthcare sector in our efforts against COVID-19." - Dr. Seth Toback, Senior Vice President, Global Medical Affairs at @Novavax
Read more: covidrive.eu/2022/02/08/covidrive-welcomes-three-new-vacc… -
Novavax
@Novavax
Excited to see another option in the fight against COVID-19 arriving in Australia.
-
Novavax
@Novavax
We are pleased to announce that Medsafe at the @minhealthnz has granted provisional approval of Novavax’ COVID-19 vaccine - the first protein-based #covid19vaccine in New Zealand. Read more: ir.novavax.com/press-releases/2022-02-03-New-Zealands-Med…
-
Novavax
@Novavax
Today, the Medicines and Healthcare products Regulatory Agency (@MHRAgovuk) has granted conditional marketing authorization of Novavax’ COVID-19 vaccine – the first protein-based #covid19vaccine authorized for use in Great Britain. Learn more: ir.novavax.com/press-releases/2022-02-03-Medicines-and-He…
-
Novavax
@Novavax
We are pleased to announce that we have submitted our request for Emergency Use Authorization (EUA) to the @FDA for the first protein-based #covid19vaccine candidate in the United States of America. Read more: ir.novavax.com/press-releases/2022-01-31-Novavax-Submits-…
-
Novavax
@Novavax
PRESS RELEASE: Novavax and Israel Announce Advance Purchase Agreement for Supply of COVID-19 Vaccine: ir.novavax.com/press-releases/2022-01-28-Novavax-and-Isra…
-
Novavax
@Novavax
Today, the Therapeutic Goods Administration (@TGAgovau) has granted approval for provisional registration of Novavax’ COVID-19 vaccine – the first-protein based #covid19vaccine authorized for use in Australia: ir.novavax.com/press-releases/2022-01-19-Australia-Therap…
-
Novavax
@Novavax
Novavax is a proud sponsor of today's @BlueStarFamily Town Hall Series on #covid19 in 2022. We look forward to the conversation on what military and veteran communities need to know about the #omicronvariant. Register and tune in at 3pm ET: bluestarfam.org/hf-town-halls/mcfcv3/?sf158708269=1
-
Novavax reposted
Blue Star Families 🇺🇸
@BlueStarFamily
We asked for your questions and we got them!
The most popular questions we heard were about keeping our kids safe.
Join us on Tuesday to find out the answers from the experts www.tfaforms.com/4955400
#bsftownhallseries
Brought to you by @CVSHealth @TriWest and @Novavax -
Novavax
@Novavax
We are pleased to announce that the South Korea Ministry of Food and Drug Safety (MFDS) has granted Biologics License Application (BLA) approval of the first protein-based #covid19vaccine candidate. Read more: ir.novavax.com/press-releases/2022-01-12-South-Korea-Mini…
-
Novavax
@Novavax
Novavax and our partner @SerumInstIndia have completed the submission for Emergency Use Authorization (EUA) of our protein-based #covid19vaccine to the @SAHPRA1 in South Africa. Learn more: ir.novavax.com/press-releases/2022-01-10-Novavax-and-Seru…
-
Novavax
@Novavax
At Novavax, we never rest on our quest to protect the health of people of everywhere. We’re excited to share our mission and humbled to present our growing list of accomplishments at the 2022 @JPMorgan Healthcare Conference. ir.novavax.com/press-releases/2022-01-04-Novavax-to-Parti… #jpmhc22
-
Novavax
@Novavax
Novavax submits final data packages to U.S. FDA as prerequisite to Emergency Use Authorization (EUA) application request for COVID-19 Vaccine Candidate. Learn more: ir.novavax.com/press-releases/2021-12-31-Novavax-Submits-…
-
Novavax
@Novavax
Novavax & @SerumInstIndia announce the Drugs Controller General of India (DCGI) has granted emergency use authorization for Novavax' COVID-19 vaccine. The vaccine will be manufactured & marketed in India by SII under the brand name Covovax™. ir.novavax.com/press-releases/2021-12-28-Novavax-and-Seru…
-
Novavax
@Novavax
The holiday season is the perfect time to reflect on the year and be grateful. Thank you to our #covid19vaccine trial participants, partners, team members, and everyone around the world working tirelessly to fight public health threats. Happy holidays!
-
Novavax
@Novavax
Novavax and SK bioscience Expand Manufacturing Agreement: ir.novavax.com/press-releases/2021-12-23-Novavax-and-SK-b…
-
Novavax
@Novavax
Today, Novavax announced variant-specific immune responses around our NVX-CoV2373 #covid19 #vaccine booster and adolescent studies. Let’s look at what we found: ir.novavax.com/2021-12-22-Novavax-Announces-Initial-Omicr… Thread:
Post not available here, view on X
Novavax
@Novavax
Functional hACE2 inhibition responses were observed after primary vaccination for all variants. 6-month boosted responses increased vs Day 35: 6x (prototype), 10.8x (beta), 6.6x (Delta), 8.1x (Alpha) & 19.9x (Omicron).
Novavax
@Novavax
>99% wild-type neutralization responses were observed against prototype, Delta and Omicron after 2 doses and boosted above peak levels.
Post not available here, view on X
Novavax
@Novavax
Adolescent hACE2 receptor inhibition responses were 2.4-4-fold higher than in adults.
Novavax
@Novavax
Given the evolving pandemic, an #omicron-specific vaccine could be necessary. GMP manufacturing is expected to begin soon and we plan to initiate #clinicaltrials in the first quarter of 2022. #clinicalresearch
-
Novavax
@Novavax
Novavax announced that @WHO Strategic Advisory Group of Experts on Immunization (SAGE) has published its interim recommendations for use of NVX-CoV2373, Novavax’ recombinant nanoparticle protein-based COVID-19 vaccine with Matrix-M™ adjuvant: ir.novavax.com/press-releases/2021-12-21-World-Health-Org…
-
Novavax
@Novavax
Novavax Announces Initiation of PREVENT-19 COVID-19 Vaccine Phase 3 Trial Booster Study: ir.novavax.com/press-releases/2021-12-21-Novavax-Announce…
"All PREVENT-19 trial participants are now eligible to receive a third booster dose of NVX-CoV2373." -
Novavax
@Novavax
The World Health Organization (@WHO) grants second Emergency Use Listing (EUL) for Novavax' COVID-19 Vaccine.
Novavax
@Novavax
EUL is a prerequisite for Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) to be exported to numerous countries participating in the COVAX Facility.
-
Novavax reposted
European Commission
@EU_Commission
Today, we add a fifth vaccine to our portfolio of safe and effective vaccines.
Following the recommendation of @EMA_News, we have granted conditional marketing authorisation for the Nuvaxovid vaccine, developed by @Novavax.
#safevaccines -
Novavax
@Novavax
The European Commission (@EU_Commission) has granted Novavax conditional marketing authorization for Nuvaxovid™ COVID-19 Vaccine (recombinant, adjuvanted) for active immunization to prevent #covid19 caused by SARS-CoV-2 in individuals 18+. Learn more: ir.novavax.com/press-releases/2021-12-20-European-Commiss…
-
Novavax reposted
Ursula von der Leyen
@vonderleyen
We have now authorised the @Novavax vaccine.
With 5 approved vaccines, the EU has a varied portfolio, based both on novel technologies, such as mRNA, and classic ones, like Novavax, which is protein-based.
Vaccination, and boosters, are our best protection against COVID19. -
Novavax
@Novavax
We are pleased to announce that the European Medicines Agency has recommended granting a conditional marketing authorization for Novavax’ Covid-19 vaccine Nuvaxovid (also known as NVX-CoV2373) to prevent COVID-19 in people from 18 years of age. Learn more: ir.novavax.com/press-releases/2021-12-20-Novavax-Receives…
-
Novavax
@Novavax
We are pleased to announce that the @WHO has granted Emergency Use Listing for Novavax’ NVX-CoV2373, making this the first protein-based COVID-19 vaccine listed for use by the WHO. This vaccine will be marketed by @SerumInstIndia as Covovax. Read more: ir.novavax.com/press-releases/2021-12-17-Novavax-and-Seru…
-
Novavax reposted
Adar Poonawalla
@adarpoonawalla
This is yet another milestone in our fight against COVID-19, Covovax is now W.H.O. approved for emergency use, showing excellent safety and efficacy. Thank you all for a great collaboration, @Novavax @WHO @GaviSeth @Gavi @gatesfoundation www.who.int/news/item/17-12-2021-who-lists-9th-covid-19-v…
-
Novavax
@Novavax
Our partner @TakedaPharma has completed their submission for a New Drug Application of the first protein-based #covid19vaccine to the @MHLWitter_en in Japan. Learn more: ir.novavax.com/press-releases/2021-12-15-Novavax-Announce…
-
Novavax
@Novavax
Novavax Statement on PREVENT-19 Phase 3 Clinical Trial Results Publication in the @NEJM: ir.novavax.com/Novavax-Statement-on-PREVENT-19-Phase-3-Cl… #covid19
-
Novavax
@Novavax
We're thrilled to announce that PREVENT-19 (US/Mex Phase 3) results were submitted for publication. The manuscript is now available as a pre-print. Let's dive into what we found. Thread: www.medrxiv.org/content/10.1101/2021.10.05.21264567v1
Post not available here, view on X
Novavax
@Novavax
For a 1-page factsheet on PREVENT-19, visit: www.novavax.com/sites/default/files/2021-06/Novavax-PREVE… (English) and www.novavax.com/sites/default/files/2021-06/Novavax-PREVE… (Espanol) #clinicalresearch
Novavax
@Novavax
Thank you. Novavax is grateful to the thousands of people around the world who are volunteering for our vaccine studies. We thank the U.S. Government, @CEPIvaccines & other governments for their significant support of our work.
Novavax
@Novavax
Today, the full results from PREVENT-19, Novavax’ pivotal Phase 3 clinical trial of NVX-CoV2373, a recombinant protein nanoparticle vaccine against #covid19, were published in the @NEJM.
The paper may be accessed here: www.nejm.org/doi/full/10.1056/NEJMoa2116185?query=feature… -
Novavax
@Novavax
Thank you to @BioBuzzMaryland and to all the voters for recognizing Novavax as Employer of the Year. While we had an amazing 2020 and 2021, the best is yet to come. Join us: novavax.com/careers
-
Novavax
@Novavax
We are pleased to announce that Novavax has submitted a regulatory filing to the Ministry of Health and Prevention (@mohapuae) for emergency use of our #covid19vaccine in the United Arab Emirates (UAE). Learn more: ir.novavax.com/press-releases/2021-12-13-Novavax-Files-fo…
-
Novavax
@Novavax
On behalf of Novavax, we wanted to express our deepest sympathies on the passing of Suresh Jadhav. He was truly a remarkable man and did so much for the
@SerumInstIndia family, but also for global health. Please know we are all thinking of you during this difficult period.
Adar Poonawalla
@adarpoonawalla
The @SerumInstIndia family and the Indian vaccine industry has lost a guiding light, with the passing of Dr. Suresh Jadhav. My prayers are with his family during these trying times and I thank you all, for your condolences.
-
Novavax
@Novavax
Novavax Statement on Omicron Variant Response: ir.novavax.com/press-releases/Novavax-Statement-on-Omicro… #covid19vaccines
-
Novavax
@Novavax
This Thanksgiving, we're thankful for the tens of thousands of Novavax clinical trial participants around the world. Thank you!
-
Novavax
@Novavax
We are pleased to announce our submission to the Singapore Health Sciences Authority (HSA) for interim authorization of its #covid19vaccine under the Pandemic Special Access Route (PSAR). More info: ir.novavax.com/press-releases/2021-11-24-Novavax-Files-fo…
-
Novavax
@Novavax
PRESS RELEASE: Novavax Confirms European Medicines Agency Review of COVID-19 Vaccine Filing for Conditional Marketing Authorization ir.novavax.com/2021-11-17-Novavax-Confirms-European-Medic…
-
Novavax
@Novavax
The @FDAPhilippines has issued Emergency Use Authorization (EUA) for Covovax/Recombinant Spike Protein of SARS-CoV-2 Virus 5 mcg for active immunization of individual 18+ for the prevention of coronavirus disease 2019 caused by SARS-CoV-2. ir.novavax.com/press-releases/2021-11-17-Novavax-and-Seru…
Novavax
@Novavax
The Novavax COVID-19 vaccine is not authorized or licensed by the U.S. FDA.
-
Novavax
@Novavax
We are pleased to announce that Novavax and SK Bioscience have submitted to the Ministry of Food and Drug Safety (MFDS) for the first protein-based #covid19vaccine candidate in South Korea: ir.novavax.com/press-releases/2021-11-15-Novavax-Announce…
-
Novavax
@Novavax
ANNOUNCEMENT: @CDCgov guidance states that UK & Mexico Phase 3 clinical trial participants are considered fully vaccinated if they received the full series of active Novavax COVID-19 vaccine. Novavax is grateful to our clinical trial participants. ir.novavax.com/press-releases/Novavax-Statement-on-UK-and…
-
Novavax
@Novavax
We are pleased to announce the completion of Novavax' rolling submission to the World Health Organization (@WHO) for emergency use listing (EUL) of NVX-CoV2373, our protein-based COVID-19 vaccine candidate: ir.novavax.com/press-releases/2021-11-04-Novavax-Files-CO…
-
Novavax
@Novavax
We are pleased to announce that we have submitted for provisional approval to New Zealand Medicines and Medical Devices Safety Authority (Medsafe) @minhealthnz for the first protein-based #covid19vaccine candidate in New Zealand: ir.novavax.com/press-releases?sf153856190=1
-
Novavax
@Novavax
Novavax and @SerumInstIndia announce that the National Agency of Drug and Food Control of the Republic of Indonesia @BPOM_RI, has granted emergency use authorization (EUA) for our #covid19vaccine. Learn more: ir.novavax.com/2021-11-01-Novavax-and-Serum-Institute-of-…
Novavax
@Novavax
This is the first protein-based #covid19 vaccine authorized by a regulatory agency which is a historical milestone for Novavax, in partnership with @SerumInstIndia, and exemplifies our commitment to equitable global access.
-
Novavax
@Novavax
We are pleased to announce that we have completed all submissions needed for Rolling Review to European Medicines Agency @EMA_News in the EU. ir.novavax.com/press-releases/2021-11-01-Novavax-Files-fo…
-
Novavax
@Novavax
We are pleased to announce our submission for authorization to Health Canada @GovCanHealth for the first protein-based #covid19vaccine candidate in Canada. ir.novavax.com/press-releases/2021-11-01-Novavax-Files-fo…
-
Novavax
@Novavax
We are pleased to announce the completion of our rolling submission to the Therapeutic Goods Administration (TGA) for provisional approval of the first protein-based #covid19vaccine candidate in Australia. ir.novavax.com/press-releases/2021-10-29-Novavax-Files-fo… @TGAgovau
-
Novavax
@Novavax
We are pleased to announce that we have submitted a CMA Application for the first protein-based #covid19vaccine candidate in the United Kingdom to the Medicines Healthcare products and Regulatory Agency @MHRAgovuk ir.novavax.com/press-releases/2021-10-27-Novavax-Files-fo…
-
Novavax
@Novavax
Vaccines help save around four to five million lives each year. This life-saving promise is why we turn up to work every day – and now, we are about to embark on our journey to help fight #covid19. Here’s our story: www.linkedin.com/pulse/who-novavax-novavax/?sf153202611=1
-
Novavax
@Novavax
Novavax Reconfirms Confidence in Regulatory Filing Timelines and Manufacturing Quality: ir.novavax.com/press-releases/Novavax-Reconfirms-Confiden…
-
Novavax
@Novavax
Novavax to Participate in World Vaccine Congress Europe: ir.novavax.com/press-releases/2021-10-15-Novavax-to-Parti… #wvceu
-
Novavax
@Novavax
Inspired by hope, powered by innovation, and grounded in science— today we are moving our brand forward. Our new brand brings to life our quest to protect the health of people everywhere. Stay tuned for more updates on our progress!
-
Novavax
@Novavax
Lisa Dunkle, M.D., Vice President, Global Medical Lead, at Novavax will be a panelist at the 2021 Maryland Life Sciences Bio Innovation Conference.
For more information and details: ir.novavax.com/press-releases/2021-09-29-Novavax-to-Parti… -
Novavax
@Novavax
Thank you. Novavax is grateful to the thousands of people around the world who are volunteering for our vaccine studies. We thank the U.S. Government, @CEPIvaccines & other governments for their significant support of our work.
-
Novavax
@Novavax
We’re proud to announce the publication of our successful Phase 3 trial of NanoFlu™, our seasonal quadrivalent Nanoparticle #influenza #vaccine (#qniv) candidate, in @TheLancetInfDis. Let’s dig into why it matters: www.thelancet.com/journals/laninf/article/PIIS1473-3099(2…
Thread:Post not available here, view on X
Novavax
@Novavax
Further, existing flu vaccines have shown 3 other limitations: 1) induction of antibody responses that may not cross-protect against increasingly frequent antigenic drift of flu viruses; pubmed.ncbi.nlm.nih.gov/31102401
Novavax
@Novavax
2) lower immune responses in older adults #immunosenescence;
Post not available here, view on X
Novavax
@Novavax
Why it matters: Higher titers may mean more protection. Broader responses may mean protection against antigenic drift during and between flu seasons. Memory responses may improve durability of protection.
Novavax
@Novavax
Novavax is encouraged by these findings and looks forward to the continued development of our candidates. We recently launched a Phase 1/2 study that combines NanoFlu with our COVID-19 vaccine candidate.
-
Novavax
@Novavax
Today, @NEJM published the paper describing our #uk Phase 3 #clinicaltrial results, along with a great Quick Take video. Check it out: www.nejm.org/do/10.1056/NEJMdo006164/full/?sf151638394=1 #clinicalresearch #covid19 #vaccines
-
Novavax
@Novavax
Novavax will participate in a fireside chat at the 2021 Cantor Virtual Global Healthcare Conference. Further details are available at ir.novavax.com/press-releases/2021-09-23-Novavax-to-Parti…
-
Novavax
@Novavax
NEWS RELEASE: Novavax and @SerumInstIndia Announce Submission to the World Health Organization for Emergency Use Listing of Novavax' COVID-19 Vaccine Candidate ir.novavax.com/press-releases/2021-09-23-Novavax-and-Seru…
-
Novavax
@Novavax
WATCH: @jtrizzino's full interview with @JennyLeiRavelo at @devex this week: www.devex.com/news/novavax-evp-it-s-up-to-policymakers-to… #unga76
-
Novavax reposted
Jenny Lei Ravelo
@JennyLeiRavelo
My interview with @Novavax @jtrizzino www.devex.com/news/novavax-evp-it-s-up-to-policymakers-to…
#devexevent @ #unga76 -
Novavax
@Novavax
Novavax Statement on Proof of COVID-19 Vaccine Requirements for PREVENT-19 Clinical Trial Participants in the U.S.: ir.novavax.com/press-releases/Novavax-Statement-on-Proof-…
-
Novavax
@Novavax
NEWS RELEASE: Novavax to Participate in University of Oxford Com-COV3 Study Comparing Mixed COVID-19 Vaccine Schedule in Adolescents ir.novavax.com/press-releases/2021-09-16-Novavax-to-Parti…
-
Novavax
@Novavax
Novavax Statement on Takeda Agreement to Provide 150 Million Doses of NVX-CoV2373 to the Government of Japan: ir.novavax.com/press-releases/Novavax-Statement-on-Takeda…
-
Novavax
@Novavax
Novavax is pleased to announce the start of a new #clinicaltrial. This Phase 1/2 study will evaluate the safety & immunogenicity of a new investigational candidate: our COVID-NanoFlu™ Combination Vaccine. Thread:
Post not available here, view on X
Novavax
@Novavax
What do we know about this combination vaccine so far? In a recent pre-clinical study, the combination showed robust responses to both influenza A and B & protected against the #sars-CoV-2 #covid19 virus: www.biorxiv.org/content/10.1101/2021.05.05.442782v1
Novavax
@Novavax
A sub-study of the UK Phase 3 showed that co-administration of our NVX-CoV2373 vaccine candidate along with a seasonal influenza vaccine was well-tolerated and showed similar efficacy to NVX-CoV2373 administered alone: www.medrxiv.org/content/10.1101/2021.06.09.21258556v1
Post not available here, view on X
Novavax
@Novavax
Thank you. Novavax is grateful to the thousands of people around the world who are volunteering for our vaccine studies. We thank the U.S. Government and @CEPIvaccines for their significant support of our work.
Novavax
@Novavax
Learn about our investigational vaccine candidate and Novavax #vaccine technology at novavax.com
-
Novavax
@Novavax
NEWS RELEASE: Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza www.prnewswire.com/news-releases/novavax-initiates-phase-… #covid19
-
Novavax reposted
Reuters Health
@Reuters_Health
Participants in Novavax Inc's late-stage COVID-19 vaccine trial can be considered fully vaccinated two weeks after completing their two-dose vaccine regimen, the U.S. Centers for Disease Control and Prevention said on Monday. www.reuters.com/business/healthcare-pharmaceuticals/novav…
-
Novavax
@Novavax
PRESS RELEASE: Novavax Statement on @CDCgov Guidance Update for COVID-19 Clinical Trial Participants ir.novavax.com/press-releases/2021-08-30-Novavax-Statemen… #covid19
-
Novavax
@Novavax
STATEMENT: Novavax to Participate in OCTAVE-DUO Study to Evaluate Third Dose of Vaccine in Participants with Impaired Immune Systems ir.novavax.com/press-releases/2021-08-25-Novavax-to-Parti… #covid19
-
Novavax reposted
The Business Journals
@bizjournals
Novavax just added some new — and familiar — faces to its executive team. The appointments are the latest in a series of additions the Gaithersburg vaccine maker has made throughout the pandemic to its leadership and board. www.bizjournals.com/washington/news/2021/08/17/novavax-ne…
-
Novavax reposted
Stella Kyriakides
@SKyriakidesEU
✅Signing the @Novavax #covid19 contract for up to 200 million more doses between 2021 and 2023.
We are adding a promising vaccine technology to our portfolio and ensuring vaccine supply for 🇪🇺 and 🌍citizens as we prepare for the months ahead. -
Novavax
@Novavax
NEWS: Novavax Appoints Biopharmaceutical Veterans Jim Kelly as Chief Financial Officer and Nasir Egal, Ph.D., as Senior Vice President of Quality Assurance ir.novavax.com/press-releases/2021-08-16-Novavax-Appoints…
-
Novavax
@Novavax
NEWS: Novavax Reports Second Quarter 2021 Financial Results and Operational Highlights ir.novavax.com/2021-08-05-Novavax-Reports-Second-Quarter-…
Full deck: ir.novavax.com/image/Q2-2021-Earnings-Slides.pdf -
Novavax
@Novavax
NEWS: Novavax Announces #covid19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination ir.novavax.com/2021-08-05-Novavax-Announces-COVID-19-Vacc…
Post not available here, view on X
Novavax
@Novavax
This post-boost consistency suggests a maturation of the immune response.
Novavax
@Novavax
A third dose was generally well tolerated. Local & systemic symptoms showed a favorable, consistent reactogenicity profile. 90% of symptoms rated as mild or moderate after the third dose.
Post not available here, view on X
Novavax
@Novavax
Further, immune responses were not significantly changed when both #covid and #flu vaccines were given, suggesting they can be used together in an annual vaccination campaign.
Novavax
@Novavax
Together, this new data support the use of our NVX-CoV2373 vaccine in a boosting campaign. See the full presentation and learn more: ir.novavax.com/image/Q2-2021-Earnings-Slides.pdf
-
Novavax
@Novavax
NEWS: Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax’ Recombinant Nanoparticle #covid19 Vaccine ir.novavax.com/2021-08-05-Novavax-and-Serum-Institute-of-…
Post not available here, view on X
Novavax
@Novavax
“This important step toward access to millions of doses of a safe and effective vaccine for countries with an urgent need to control the pandemic was made possible through our strategic partnership with @SerumInstIndia, and it demonstrates the power of global collaboration.”
-
Novavax reposted
Ursula von der Leyen
@vonderleyen
As variants are spreading, we need to stay vigilant.
We approved a new contract with @Novavax for 200 million doses of its vaccine, which is already being tested successfully against variants.
With our broad vaccine portfolio we protect Europeans and help vaccinate the world. -
Novavax
@Novavax
NEWS: Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine ir.novavax.com/press-releases/2021-08-04-Novavax-and-Euro… #covid19
-
Novavax reposted
ARCHIVED: Rep. David Trone
@RepDavidTrone
Thank you @Novavax for inviting me to tour your facility in Gaithersburg.
Not only are you bringing new jobs to @MontgomeryCoMD but you are also on your way to bringing us a new COVID-19 vaccine.
This is how we beat the pandemic and get back to normal! -
Novavax
@Novavax
We enjoyed hosting @RepDavidTrone today at our headquarters in Gaithersburg, MD. Dr. Nita Patel, who leads our vaccine development program, updated him on our progress and next steps.
-
Novavax
@Novavax
RELEASE: Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in @NEJM, Demonstrating High Levels of Efficacy of #covid19 Vaccine ir.novavax.com/press-releases/2021-06-30-Novavax-Publishe…
-
Novavax
@Novavax
Novavax Statement on Proof of Vaccination for Phase 3 Clinical Trial Participants: ir.novavax.com/press-releases/2021-06-30-Novavax-Statemen… #covid19
-
Novavax
@Novavax
Join Novavax' Lisa Dunkle, our VP of Clinical Development and Global Medical Lead for the #covid19 vaccine candidate at the @IAmBiotech Clinical Trial Diversity Summit today.
For more details and registration: www.bio.org/events/bio-clinical-trial-diversity-summit?sf… #ctdsummit #bioequality -
Novavax
@Novavax
Novavax is proud to announce that Lisa Dunkle, our VP, Clinical Development & Global Medical Lead for the #covid19 vaccine candidate, will be speaking at the @IAmBiotech Clinical Trial Diversity Summit tomorrow.
More information: www.bio.org/events/bio-clinical-trial-diversity-summit?sf… #ctdsummit #bioequality -
Novavax
@Novavax
Novavax Statement on Completion of the National Research Council of Canada Biologics Manufacturing Centre: ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
Novavax CEO Stanley Erck today addressed @BIOConvention and discussed why transferring intellectual property doesn't get vaccines to the world faster. Get the recap on the live blog: convention.bio.org?sf145821403=1 #biodigital
-
Novavax
@Novavax
RELEASE: Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously ir.novavax.com/news-releases/news-release-details/novavax… #covid19
-
Novavax
@Novavax
DATOS NUEVOS DISPONIBLES: La vacuna contra #covid19 de Novavax demuestra 90% de eficacia en general y 100% de protección contra enfermedad moderada y severa en el estudio en fase 3 PREVENT-19. Lea más en: www.novavax.com/sites/default/files/2021-06/Novavax-PREVE…
-
Novavax
@Novavax
Important news for our UK #clinicaltrial participants, read more from @NHSuk:
Department of Health and Social Care
@DHSCgovuk
Deputy Chief Medical Officer Professor Jonathan Van-Tam has written to UK residents who have volunteered to take part in #covid19 vaccine studies.
Read the full letter here 🔻
www.gov.uk/government/publications/letter-from-the-deputy… -
Novavax
@Novavax
Today, Novavax is excited to announce results of our PREVENT-19 Phase 3 #clinicaltrial in the US & Mexico, evaulating the safety and efficacy of NVX-CoV2373, our investigational #covi19 #vaccine candidate. Thread:
Post not available here, view on X
Novavax
@Novavax
In April, PREVENT-19 began the "crossover" portion of the trial, allowing participants to be fully vaccinated while remaining blinded, maintaining the integrity of the trial. Read about the crossover here:
Novavax
@Novavax
On April 20, we began the "crossover" for PREVENT-19, the US/Mexico Phase 3 clinical trial of our investigational #covid19 #vaccine candidate. Follow below to go behind the scenes of this vital #clinicalresearch. Thread:
Novavax
@Novavax
PREVENT-19 enrolled 29,960 participants across 113 sites in the US & 6 sites in Mexico. 2:1 randomization of active vaccine to placebo groups meant that participants had a 2-in-3 chance of receiving active vaccine.
Post not available here, view on X
Novavax
@Novavax
We expect to share further details as additional data become available. The placebo-controlled portion of PREVENT-19 continues in the 12-17 age group, which recently completed enrollment of 2,248 participants.
Novavax
@Novavax
Learn about our investigational vaccine candidate, Novavax #vaccine technology, our #covid19 #clinicaltrial results and more at: www.novavax.com/covid-19-coronavirus-vaccine-candidate-up…
-
Novavax
@Novavax
NEW DATA RELEASE: Novavax #covid19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
"Novavax is on the precipice of a new #covidvaccine. It's building out a new Gaithersburg HQ as it grows." via @WBJonline www.bizjournals.com/washington/news/2021/06/10/novavax-co…
-
Novavax
@Novavax
Novavax CEO says Gaithersburg campus could have 800 employees by year’s end: bethesdamagazine.com/2021/06/10/novavax-ceo-says-gaithers… via @Bethesda_Mag #mdjobs
-
Novavax
@Novavax
NEWS RELEASE: Novavax Announces Positive Data from Three Complimentary Studies of #covid19 Beta (B.1.351) Variant Strain Vaccine ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
“We’re building the headquarters of what will be I think one of the great, great vaccine companies not only of our nation, but the world." - Robert Redfield, former CDC Director and Novavax advisor wtop.com/maryland/2021/06/novavax-opens-new-gaithersburg-…
-
Novavax
@Novavax
The company’s growth has been quick: A year ago, there were about 100 people working in Montgomery County, and CEO Stan Erck said... that number will be much higher by the end of 2021. “We’re not stopping. We hire new people every single week.” wtop.com/maryland/2021/06/novavax-opens-new-gaithersburg-… #mdjobs
-
Novavax
@Novavax
“While #covid19 put the work of Novavax into the spotlight over the past year, your lifesaving contributions to science and medicine don’t stop there... You have been a valued member of Maryland’s biotech community for decades..." - @GovLarryHogan www.wbal.com/hogan-tours-new-novavax-global-headquarters-…
-
Novavax
@Novavax
“It’s an exciting day for @MontgomeryCoMD and the state of Maryland and especially for Novavax... I got a chance to see firsthand some of the cutting edge research that this company has been doing,” - @GovLarryHogan cbsloc.al/2Sjby6S
-
Novavax reposted
Governor Larry Hogan
@GovLarryHogan
Today I was pleased to tour the site of @Novavax’s future headquarters in Gaithersburg. We are so proud that Novavax calls Maryland home, and we are thrilled that they are further expanding their footprint here.
-
Novavax
@Novavax
WATCH LIVE AT 10AM: Maryland @GovLarryHogan tours site of the future Novavax Vaccines Innovation Campus and Global Headquarters www.youtube.com/watch?v=n5FjGu2tdLA&sf145565835=1
-
Novavax
@Novavax
Novavax is excited to welcome Maryland @GovLarryHogan this Thursday at site of the future Novavax Vaccines Innovation Campus and Global Headquarters: ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
Join Novavax CEO Stanley Erck at the "Global Pandemic Preparedness" panel at @BIOConvention Digital 2021 on June 14.
Further details and registration: ir.novavax.com/news-releases/news-release-details/novavax… #biodigital -
Novavax
@Novavax
On April 20, we began the "crossover" for PREVENT-19, the US/Mexico Phase 3 clinical trial of our investigational #covid19 #vaccine candidate. Follow below to go behind the scenes of this vital #clinicalresearch. Thread:
Post not available here, view on X
Novavax
@Novavax
Rachel was motivated to remain in the study despite being eligible for EUA vaccines prior to her crossover appointment. “I felt like the vaccine was more important than these few weeks.”
Novavax
@Novavax
For Daylia (left), a member of the trial site staff, PREVENT-19 is the first study she has worked on from start to finish, building skills for what she hopes is an exciting career in #clinicalresearch.
Post not available here, view on X
Novavax
@Novavax
We're also grateful to trial site staff & key partners like Research Your Health and @ICONplc, who help us conduct this #clinicalresearch. #ictd2021
Novavax
@Novavax
Learn about our investigational vaccine candidate, Novavax #vaccine technology, our #covid19 #clinicaltrial results and more at: www.novavax.com/covid-19-coronavirus-vaccine-candidate-up…
Post not available here, view on X
Novavax
@Novavax
Learn about our investigational vaccine candidate, Novavax #vaccine technology, our #covid19 #clinicaltrial results and more at: www.novavax.com/covid-19-coronavirus-vaccine-candidate-up…
-
Novavax
@Novavax
WATCH: @CNBC’s @MegTirrell interviews @Novavax CEO Stanley Erck on timelines for our #covid19 vaccine candidate and plans for a flu/COVID vaccine trial in 2021: cnb.cx/3p0N51Y
-
Novavax
@Novavax
RELEASE: Novavax to Participate in @Jefferies Virtual Healthcare Conference ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
RELEASE: Novavax to Present at International Society for Vaccines Virtual Congress COVID-19 Vaccine Update ir.novavax.com/news-releases/news-release-details/novavax… #covid19
-
Novavax
@Novavax
RELEASE: Novavax Announces Memorandum of Understanding to Explore Expansion of COVID-19 Vaccine Activities in South Korea ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
STATEMENT: Novavax Statement on Proof of Vaccination for Phase 3 Clinical Trial Participants in the United Kingdom ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
The Roundtable took place ahead of @TheBlueHouseENG summit with @POTUS.
Erck will represent Novavax at a @WhiteHouse press conference today at 5:00 pm. Tune in: www.youtube.com/watch?v=iKGSn4qOR9Y&sf144157280=1 -
Novavax
@Novavax
Today, Stan Erck, our President and CEO, participated in a CEO Roundtable between the United States and South Korea, hosted by @SecRaimondo. Novavax highlighted our partnership with SK Bioscience, which will provide the Korean people with 40 million doses of our vaccine.
-
Novavax
@Novavax
STATEMENT: Complete Trial Results Manuscript of Novavax COVID-19 Investigational Vaccine Posted to Preprint Server medRxiv ir.novavax.com/news-releases/news-release-details/complet… #covid19
-
Novavax
@Novavax
STATEMENT: Novavax Statement on Participation in Mix-and-Match COVID-19 Vaccine Booster Trial in the United Kingdom ir.novavax.com/news-releases/news-release-details/novavax… #covid19
-
Novavax
@Novavax
Thanks to @MDTechCouncil for naming @Novavax Life Sciences Company of the Year and our CEO Stanley Erck, CEO of the Year for Life Sciences at the 2021 Industry Awards Celebration.
Join our team of #supernovas at www.novavax.com/people-culture?sf144042732=1 #mdtech #mdjobs -
Novavax
@Novavax
PRESS RELEASE: Novavax Reports First Quarter 2021 Financial Results and Operational Highlights
ir.novavax.com/news-releases/news-release-details/novavax… -
Novavax
@Novavax
PRESS RELEASE: Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
Novavax Statement in Opposition to the WTO TRIPS Waiver
Full Statement: ir.novavax.com/news-releases/news-release-details/novavax…
Our Commitment to Accelerating Equitable Access: ir.novavax.com/news-releases/news-release-details/novavax… -
Novavax
@Novavax
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
We are pleased to announce an expansion of our agreement with @SerumInstIndia to manufacture antigen for #nvxcov2373, our #covid-19 #vaccine candidate. Read today’s announcement to learn more: ir.novavax.com/news-releases/news-release-details/novavax…
-
Novavax
@Novavax
Thanks @IAmBiotech for talking w/ our CEO Stan Erck about what’s needed for a #covid #vaccine to succeed in stemming the #pandemic & exciting Ph1 results for #nvxcov2373, our recombinant #nanoparticle vaccine candidate. Looking forward to the next conversation w/ @DrMichelleBIO!
Biotechnology Innovation Organization
@IAmBiotech
BIO member @Novavax has launched the phase 2b clinical trial of its #covid19 vaccine, bringing it one step closer to approval. Novavax President & CEO Stan Erck joins this timely episode of #iambio to talk about their promising technology. Listen here: podcasts.apple.com/us/podcast/respiratory-rescue/id148556…
-
Novavax
@Novavax
We are proud to announce a collaboration with @SerumInstIndia to develop and commercialize our #covid19 #vaccine candidate for LMIC ; an important 1st step to ensure a global supply during worldwide pandemic. Read it here: ir.novavax.com/news-releases/news-release-details/novavax…. #nvxcov2373
-
Novavax
@Novavax
$NVAX is very excited to have just announced initiation of the #phase1 portion of the Phase 1/2 clinical trial for #nvxcov2373, our #covid19 #vaccine . Read our news release to learn more to learn more at ir.novavax.com/news-releases/news-release-details/novavax…. #novavax2020
-
Novavax
@Novavax
CEPI
@CEPIvaccines
COVID-19 is having a huge impact on individuals, societies, and economies 🌍
We've announced a further $4.4 million funding to
@NovavaxInc and @UniofOxford to develop additional vaccine candidates against the virus 👩🔬👉 cepi.net/cepi-expands-investment-covid-19-vaccine-develop…

















































































































































































































































































































































